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RESUMO 
A metanfetamina é uma droga de abuso altamente viciante e um potente 
estimulador do sistema nervoso central capaz de induzir danos em diferentes células e 
sistemas, como por exemplo o sistema dopaminérgico, serotoninérgico e glutamatérgico. 
De facto, a metanfetamina exerce inúmeros efeitos neurotóxicos entre os quais stresse 
oxidativo, excitotoxicidade e disfunção mitocondrial. Os níveis elevados de dopamina e 
glutamato levam à produção excessiva de espécies reactivas de nitrogénio e oxigénio. 
Recentemente, foi também sugerido que a metanfetamina compromete a integridade da 
barreira hematoencefálica. Esta barreira, ou mais especificamente a unidade neuronal-
glial-vascular que é constituída por células endoteliais cerebrais, lâmina basal, neurónios, 
astrócitos, pericitos e microglia. Uma vez que a barreira hematoencefálica é uma 
estrutura complexa que providencia uma interface seletiva mas dinâmica entre a 
circulação periférica e o sistema nervoso central, alterações ao nível da sua função 
podem levar a lesões cerebrais. Quando a homeostase do cérebro é perturbada, ocorre 
uma reacção inflamatória envolvendo diversos tipos de células e moléculas, o que pode 
culminar com a morte celular. O processo neuroinflamatório envolve uma resposta 
complexa de todas as células do sistema nervoso central, incluindo neurónios, astrócitos, 
microglia e células endoteliais. Sabe-se que a metanfetamina é capaz de induzir 
neuroinflamação, contudo os seus efeitos específicos nas células da microglia e células 
endoteliais tem sido pouco estudado. Assim sendo, o objectivo do presente trabalho foi 
avaliar a resposta das células da microglia e endoteliais a um estímulo com 
metanfetamina, olhando especificamente para o stresse nitrosativo e oxidativo, usando 
duas linhas celulares como modelo de microglia e de células endoteliais, N9 e bEnd.3, 
respectivamente.  
Neste estudo, observámos que a metanfetamina induz a libertação de nitritos em 
ambas as linhas celulares, 1 hora após a exposição a esta droga, tendo esta libertação 
sido prevenida na presença de L-NAME. Mostramos ainda que a via de sinalização 
JAK/STAT está envolvida neste efeito. Além disso, concluímos que a metanfetamina 
induziu um aumento dos níveis de 3-nitrotirosina. Apesar da rápida e transiente 
libertação de nitritos observada em ambas as linhas celulares, o aumento da produção de 
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espécies reactivas de oxigénio foi observada após 24 horas de exposição à droga, apenas 
em células da microglia. A viabilidade celular, após exposição à metanfetamina foi 
também avaliada em ambas as linhas celulares, sem nenhum efeito nas células da 
microglia. Contudo, uma diminuição da viabilidade das células endoteliais foi registada 
quando estas células foram expostas a concentrações elevadas de metanfetamina, o que 
pode ser uma possível explicação para a diminuição dos níveis de nitritos observada. 
Com o presente estudo concluímos que a metanfetamina induz uma resposta 
nitrosativa em ambas as linhas célulares, enquanto o aumento das espécies reativas de 
oxigénio só foi observado nas células da microglia. Mais ainda, o efeito da metanfetamina 
parece ser dependente da concentração e tempo de exposição. 
 
Palavras-chave: Metanfetamina, microglia, células endoteliais, óxido nítrico, 3-
nitrotirosina, espécies reactivas de oxigénio. 
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ABSTRACT 
Methamphetamine (METH) is a highly addictive drug of abuse and a potent central 
nervous system (CNS) stimulant able to induce damages to different cells and systems, 
such as dopaminergic, serotonergic and glutamatergic neurotransmission. METH-induced 
over-flow of dopamine and glutamate leads to excessive reactive nitrogen and oxygen 
species production. Indeed, this drug has several neurotoxic features that may include 
oxidative stress, excitotoxicity and mitochondrial dysfunction. Recently, it was also shown 
that METH compromises blood brain barrier (BBB) integrity. This barrier, or more 
specifically the neuro(glial)vascular unit, is composed by brain endothelial cells, basal 
lamina, neurons, astrocytes, pericytes and microglia. Since BBB is a complex structure 
that provides a restrict but dynamic interface between the peripheral circulation and the 
central nervous system (CNS), alterations in its function can lead to brain damage. When 
the homeostasis of the brain is disturbed, there is an inflammatory response involving 
several cells and molecules that can culminate in cell death. Neuroinflammatory process 
usually involves a complex response of all cells present within the CNS, including neurons, 
astrocytes, microglia and even endothelial cells. It is known that METH is able to induce a 
neuroinflammatory response, but the specific effect on microglial and endothelial cells 
have been overlooked. Thus, the present work focused on the study of METH-induced 
nitrosative and oxidative stress in both cell types, using as model two cell lines, N9 and 
bEnd.3, respectively for microglia and endothelial cells.  
We observed that METH induces nitrites release by both cell lines at 1 h after drug 
exposure, which was prevented in the presence of L-NAME. Additionally, JAK/STAT 
pathway was shown to be involved in this effect. METH was also able to increase 3-
nitrotyrosine (3-NT) levels. Despite of the quick and transient release of nitrites observed 
in both cell lines, the increase in the production of reactive oxygen species (ROS) was only 
observed at 24 h in microglial cells. Cell viability, was also evaluated in both cell lines, 
without an effect on microglial cells. However, we did observe a significant decrease in 
endothelial cell viability induced by high concentrations of METH, which can be one 
possible explanation for the decreased of nitrite levels observed.  
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Overall, we concluded that METH induces a nitrosative response in both microglial and 
endothelial cells, whereas the increase of ROS was only observed in microglial cells. 
Additionally, these effects were dependent on concentration and time exposure.  
 
Keywords: Methamphetamine, microglial cells, endothelial cells, nitric oxide, 3-
nitrotyrosine, reactive oxygen species. 
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Chapter 1 
Introduction 
 
1.1 Methamphetamine 
1.1.1 Methamphetamine consumption 
Methamphetamine (N-methyl-O-phenylisopropylamine; METH) belongs to the 
group of amphetamine-type stimulants (ATS) (Davidson et al., 2001; Berman et al., 2008). 
All the substances included in this group share structural similarity with endogenous 
neurotransmitters, the monoamines [dopamine (DA), epinephrine (E), norepinephrine 
(NE) and serotonin (5-HT)], which confers them the similar biological actions and effects. 
METH structure consists of a phenyl ring connected to an amino group by a two-carbon 
side chain with a methyl group on carbon 1 of the side chain (Fig. 1.1) (Fleckenstein et al., 
2007). This drug is also known as speed, meth, chalk, ice, crystal or glass, and can be 
consumed orally, snorted, injected or smoked (National Institute of drug abuse).   
 
 
Figure 1.1 - Chemical structure of dopamine and methamphetamine showing their structural similarities 
(adapted from Fleckenstein et al., 2007).   
 
Despite being introduced in 1893, METH did not become widely used until World 
War II, when military personnel used it to combat fatigue and increase alertness 
(Meredith et al., 2005). It was also prescribed in the 1950s and 1960s as a medication for 
depression, narcolepsy, attention deficit-hyperactivity disorder (ADHD), and obesity 
(Anglin et al., 2000; Sulzer et al., 2005; Berman et al., 2008). Nowadays, METH is 
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approved by the Food and Drug Administration (FDA) for the treatment of ADHD, 
extreme obesity and narcolepsy (Sulzer et al,. 2005). Nevertheless, it is a controlled 
substance due to its probability to induce addition (Berman et al., 2008).  The great 
expansion of the METH market in the 1980s, made it one of the most wide-spread illicit 
drugs of abuse and has developed into an epidemic across the world (Rose and Grant, 
2008). The increasing prevalence of illicit METH is in part due to its easy and low cost 
synthesis in clandestine laboratories. A number of different methods currently exist for 
synthesizing METH from legal precursor materials but the most popular, cheap, and 
simple method is the ephedrine/pseudoephedrine reduction.  
Regarding METH consumption, data from the United Nations Office on Drugs and 
Crime (UNODC) World Drug Report 2012, ATS are the second most widely used class of 
drugs worldwide, with a number of 14.3 to 52.5 million users, aged 15-64,  in 2010. In 
Portugal, according to the report from the Instituto da droga e da toxicodependência, IDT, 
(2011) between 2001 and 2007 there was an increase in amphetamines consumption 
from 0.5% to 0.9% in the total population, and from 0.6% to 1.3% in young population 
(Fig. 1.2). 
 
Figure 1.2 - Prevalence of different drugs consumption through life in total population and by young 
adults in Portugal (Annual Report of the Portuguese Institute for Drugs and Dependence, 2011). 
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1.1.2 Consequences of METH consumption 
METH abusers can experience a large variety of effects depending if there is a 
chronic or acute consumption. Instants after consumption, users experience alertness, 
wakefulness, euphoria, increased activity (Quinton et al., 2006; Kish et al., 2008), 
hyperthermia, and decrease in appetite (Yamamoto et al., 2010). Since METH has a 
relatively long half-life, about 12 hours (h), these pleasant effects can last for several 
hours (Derlet and Heischober, 1990). A chronic consumption has serious consequences 
such as renal and liver failure, life-threatening hyperthermia, cardiac arrhythmias, heart 
attacks, cerebrovascular hemorrhages, strokes, oral problems, seizures and death 
(Albertson et al., 1999; Perez et al., 1999; Donaldson and Goodchild, 2006; Darke et al., 
2008). Long-term use can also contribute to mood disturbances, confusion, anxiety, 
weight loss, insomnias, aggressiveness, social isolation and psychosis (Scott et al., 2007; 
Darke et al., 2008; Homer et al., 2008). Neuropsychological studies with human subjects 
demonstrate that METH chronic users have brain structural abnormalities, namely loss of 
gray matter, white matter hypertrophy and altered glucose metabolism in specific regions  
like hippocampus, prefrontal cortex, cingulated gyrus and amygdala (Thompson et al., 
2004; Berman et al., 2008). In fact, these findings could explain some of the problems 
identified in METH users, such as behavioral alterations, recall capacity, memory and 
performance deficits observed on verbal memory tests and executive functions like 
problem solving (Thompson et al., 2004). McCann and co-workers also made 
neuropsychiatric tests to abstinent METH users and demonstrated modest deficits in 
memory,  «executive and motor function which are known to be modulated, in part, by 
the neurotransmitter DA (McCann et al., 2008).  
 
1.1.3 Cellular mechanisms of methamphetamine-induced neurotoxicity 
1.1.1.1. Dopaminergic and serotonergic system dysfunction 
The dopaminergic and serotonergic pathways are highly affected by METH due to 
the chemical structure similarity between METH and monoaminergic neurotransmitters. 
Under physiological conditions, neuronal activation promotes the release of DA into the 
synaptic cleft and when the stimulus is ceased, DA is removed by the DA transporter 
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(DAT) to the cytoplasm and by the vesicular monoamine transporter-2 (VMAT-2) into 
vesicles for storage, release and protection from oxidation. While DA is transported to the 
vesicle, H+ is transported to the exterior of the vesicle, according to its concentration 
gradient. Such gradient is kept by an H+-ATPase.   
METH is able to diffuse through nerve terminals and consequently inducing the release of 
DA via the DAT-mediated reverse transport. Since METH shares structural similarity with 
DA (Fig 1.1), it can be also transported into the cell by DAT (Fig.1.3), leading to the release 
of DA according to its concentration gradient (Fleckenstein et al., 2007). Moreover, METH 
can be transported by VMAT to the interior of the vesicle, accumulating in its interior, 
amphetamines are weak bases, therefore intravesicular METH accepts protons, leading to 
disruption of proton electrochemical gradient essential for the DA uptake, and then DA is 
accumulated in the cytoplasm. Moreover, METH is able to redistribute VMAT-2 (Hogan et 
al., 2007) and to decrease the expression of dopamine transporters at the cell surface (by 
phosphorylation and internalization of the transporter) (Fleckenstein et al., 2007). There 
is also evidence showing that METH interferes with enzymes involved in dopaminergic 
pathway. In fact, METH increases cytosolic levels of DA by inhibiting the activity of 
monoamine oxidase (MAO), as well as increases the activity and expression of the 
dopamine synthesizing enzyme, tyrosine hydroxylase (TH) (Barr et al., 2006).  
Although, the major reports have focused mainly on the effects of METH on the 
dopaminergic system, METH administration also induces toxicity to 5-hydroxytryptamine 
terminals (5-HT) (Quinton and Yamamoto, 2006). 5-HT and DA terminals are differently 
affected by METH, since it particularly affects DA terminals in the striatum (Wagner et al., 
1980; Ricaurte et al.,  1982), but 5-HT terminals are equally sensitive to the its toxic 
effects in various brain regions including hippocampus, prefrontal cortex, amygdala, and 
striatum (Ricaurte et  al., 1982; Seiden et al., 1988). These effects in most DA markers 
(Wilson et al., 1996; Volkow et al., 2001) and 5-HT transporter (SERT) (Sekine et al., 2006) 
have also been observed in human chronic METH abusers by post-mortem analysis and 
imaging approaches. Ricaurte and McCann (1992) proposed that METH-induced DAT loss 
reflected irreversible terminal degeneration. However, studies in rodents (Friedman et al., 
1998; Cass and Manning, 1999), non-primates humans (Harvey et al., 2000) and humans 
(Volkow et al., 2001) have revealed significant recovery with protracted abstinence.  
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Studies have also emerged to show that DA plays an important role in the toxic 
effects of METH towards 5-HT axons. For example, α-methyl-p-tyrosine (AMPT), which 
was shown to protect against METH-induced toxicity towards DA axons, prevents long-
term decrease in Tryptophan hydroxylase (TPH) activity and reductions in 5-HT levels in 
the striatum and hippocampus (Krasnova and Cadet, 2009). 
 
1.1.1.2. Oxidative stress 
METH neurotoxicity is characterized by the ability to prevent DA uptake into 
vesicles or to promote the accumulation of DA into the cytoplasm. DA can be metabolized 
into 3, 4-dihydroxyphenylacetic acid (DOPAC) and hydrogen peroxide (H2O2), or non-
enzymatically auto-oxidized into cytotoxic DA-o-quinones or into DA semiquinones, with 
the production of reactive oxygen and nitrogen species non-enzymatically auto-oxidized 
into cytotoxic DA-o-quinones or into DA semiquinones, with the production of highly 
reactive superoxide anions (Fig. 1.3). These events lead to the production of reactive 
oxygen and nitrogen species (ROS and RNS, respectively), and lipid peroxidation 
(Fleckenstein et al., 2007; Yamamoto et al., 2010).  
Diverse studies demonstrated the induction of oxidative stress by METH. For 
example, Gluck and collaborators (2001) used a repeated METH treatment [4x 10 mg/kg, 
each 2 h, intraperitoneal (i.p.)] showing that METH leads to the formation of lipid and 
protein markers of oxidative stress in mice striatum and hippocampus (Gluck et al., 2001). 
The role of oxidative stress is further supported by the findings that the neurotoxic effects 
of METH can be attenuated by free radical scavengers and antioxidants (Quinton and 
Yamamoto, 2006). 
Furthermore, alterations in nitric oxide (NO) metabolism can also contribute to 
oxidative stress induced by METH (Itzhak and Ali, 2006). Wang and Angulo (2011) 
demonstrate an up-regulation of neuronal nitric oxide synthase (nNOS) and 3 
nitrotyronine (3-NT) in mice striatum, using an acute METH administration (30 mg/kg, 
i.p.).  
 
 
Chapter 1 - Introduction 
23 
1.1.1.3. Glutamatergic system deregulation 
Glutamate is the major excitatory neurotransmitter present in the mammalian 
central nervous system CNS. METH has been shown to increase the extracellular 
concentrations of glutamate (GLU) in the rat striatum (Nash and Yamamoto, 1992) and in 
the hippocampus (Rocher and Gardier, 2001). The increased extracellular GLU occurring 
during METH administration hyperactivates N-methyl-D-aspartate (NMDA) receptors 
(Fig.1.3), which increase intracellular Ca2+ that in turn activate enzymatic pathways 
leading to ROS and RNS production. Also, Ca2+ activates nitric oxide (NO) synthase with a 
consequent increased of NO levels (Fig.1.3) which can directly damage cells or react with 
superoxide to form highly reactive peroxynitrite (ONOO-; Marshall and O´Dell, 2012). In 
vitro studies demonstrate that METH-induced cell death could be prevented by the 
inhibition of Ca2+ release from endoplasmatic reticulum (Smith et al., 2010). Moreover, 
Simões and co-workers, observed that, in rat hippocampus, an acute METH 
administration (30 mg/kg, s.c.) increased glutamate receptor 2 (GluR2) and N-methyl-D-
aspartate NR2A receptor (NR2A) protein levels without changes in N-methyl-D-aspartate 
NR1 receptor (NR1) subunit (Simões et al., 2007). Although, striatal and cortical AMPA 
receptor subunit GluR2 protein levels were increased along with cortical NMDA receptor 
subunit NR1 down-regulation and NR2 up-regulation (Simões et al.2007). 
 
1.1.1.4. Mitochondrial function impairment 
The cationic lipophilic properties of METH confer the capacity to diffuse into 
mitochondria and be retained there, leading to matrix alkalinization (Sulzer and Rayport, 
1990) and disruption of the mitochondrial membrane potential (Cunha-Oliveira et al., 
2006). More specifically, METH inhibits mitochondrial electron transport chain enzyme 
complex I (Klongpanichapak et al., 2006), complex II-III (Brown et al., 2005) and complex 
IV (Burrows et al., 2000) with a consequent decrease of adenosine-5´-triphosphate (ATP) 
content in the brain and an increase of ROS  production (Fig. 1.3) (Wu et al., 2007). 
Furthermore, METH can alter mitochondria-dependent death pathway (Krasnova and 
Cadet, 2009). Jayanthi and co-workers showed that METH caused apoptotic cell death in 
frontal cortex of mice monoaminergic cells by increasing pro-apoptotic proteins, like Bax, 
Bad, Bak and Bid and decreasing anti-apoptotic proteins such as Bcl-2 and Bcl-XL and Bclw 
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(Jayanthi et al., 2001). METH also induced release of apoptosis-inducing factor (AIF), 
Smac/DIABLO and cytochrome c from mitochondria (Jayanthi et al., 2004). Activation of 
caspase-3 upon METH administration has been reported in the rat frontal cortex (Warren 
et al., 2007) and in rat cerebellar granule cells (Jiménez et al., 2004). Several in vitro 
studies also point to apoptotic features induced by METH. For example, METH leads to 
early overexpression of Bax, decrease of mitochondrial cytochrome c and activation of 
caspase cascade (Deng et al., 2002). More recently, Bento and co-workers, showed that 
METH triggered cell death of subventricular zone (SVZ) stem/progenitor cells by 
increasing caspase-3 activity (Bento et al.,2011). These studies are corroborated by others 
pointing to protection of METH-induced cell death when caspases (Jimenez et al., 2004) 
and PARP (Iwashita et al., 2004) are inhibited, or when the anti-apoptotic Bcl-2 is up-
regulated (Cadet et al., 1997).  
 
1.1.1.5. Hyperthermia 
Several studies demonstrate that hyperthermia is an important modulator of 
METH-induced toxicity to DA and 5-HT terminals. METH administration (4 x 10 mg/kg 
METH, i.p.) at room temperature produced a significant depletion of DA in the mice 
striatum, whereas equivalent doses of METH administered in a cold environment did not 
induce striatal DA and 5-HT depletions in the same brain region (Ali et al., 1994).  It was 
also proposed that METH interacts with other mediators of METH toxicity such as GLU 
neurotransmission up-regulation and oxidative stress (Yamamoto et al., 2010). In fact, the 
blockade of NMDA receptors provides a reduction of body temperature and protects 
against depletion of DA and 5-HT content and tyrosine hydroxylase (TH) activity in the 
mice striatum (Sonsala et al., 1991; Bowyer, 1995). Furthermore, inhibition of METH-
induced hyperthermia reduced ROS formation, which is able to attenuate DA toxicity in 
rat striatum (Fleckenstein et al., 1997).  
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Figure 1.3 - Mechanisms of METH neurotoxicity. METH enters into dopaminergic terminals (1), 
causing efflux of DA from intraneuronal vesicles. This DA is oxidized intracellularly, producing reactive 
species (2) such as hydrogen peroxide (H2O2) and superoxide (O2
.-), and is transported to extracellular 
spaces (3) where it is also oxidized producing reactive oxygen species (ROS). High intracellular 
concentrations of DA and METH can inhibit the electron transport chain (ETC) in mitochondria (4), 
causing leakage of high-energy electrons which trigger the formation of superoxide. METH-induced an 
increase in GLU release (5), which hyperstimulates NMDA receptors (NMDAR) on dopaminergic 
terminals to cause increases in intracellular Ca2+. Then, this Ca2+ will stimulates nitric oxide synthase 
(NOS) activity, increasing the production of nitric oxide (NO), which can combine with superoxide to 
form peroxynitrite (.ONOO–) (6). METH also stimulates microglia to release ROS and cytokines (8) 
which increase extracellular GLU levels. Finally, METH causes leakage of the BBB, allowing plasma 
proteins to enter the brain (9) (Marshall and O'Dell, 2012). 
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1.2 Neuroinflammation 
1.2.1 Innate and adaptative immune response 
Brain innate immune response against an insult is based upon the activation of the 
resident glial cells (Hauwel et al., 2005) and must be able to distinguish between self and 
non-self molecules (not expressed by host cells) designated pathogens-associated 
molecular patterns (PAMPS). Apoptotic cells also express specific molecules called 
apoptotic cell associated molecular patterns (ACAMPs). ACAMPs and PAMPs are further 
recognized by pattern recognition receptors (PRR) expressed at the surface of Toll-like 
receptors (TLRs; Gordon, 2002), the first element of contact between pathogens and the 
host (Akira et al., 2001). Sometimes, interactions between TLRs and PAMPs fail to 
eliminate the infectious agent, leading to a response by glial cells and neurons, which 
begin with the production of inflammatory cytokines, chemokines and adhesion 
molecules. These factors will induce blood-brain barrier (BBB) disruption, allowing the 
entrance of adaptive immune components into the brain (Hisanaga et al., 2001). Adaptive 
response starts with the antigen presentation of the stranger protein by antigen 
presenting cells (APC), complexed with surface major histocompatibility complex (MHC), 
to cluster of differentiation (CD)4+ or CD8+ T-cells, which became fully activated (Stone et 
al., 2006). Immune response is further propagated by other T and B cells, recruited by 
activated CD4+. Importantly, it was thought that BBB completely blocks the entrance of 
immune system cells into the brain parenchyma (Lucas et al., 2006), but nowadays it is 
known that cells and molecules of the immune system can enter the brain (Nguyen et al., 
2002). Nevertheless, the flow of immune cells from the blood to the CNS, and vice-versa, 
is highly controlled by the endothelium (Huber et al., 2001). Vascular endothelial cells are 
the target and source of inflammatory mediators (e.g. NO) and they have also a role in 
facilitating the passage of lymphocytes from blood to CNS through adhesion molecules, 
such as intercellular adhesion molecule-1 (ICAM-1) (Couraud, 1994; Wong, 1999).  
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1.2.2 Microglia 
After an injury, immune system triggers an inflammatory response in order to 
restore homeostasis. The inflammation in the CNS, neuroinflammation, is a complex 
integration of the responses of all cells present within the CNS, including neurons, 
astrocytes, microglia and the infiltrating leukocytes (Carson et al., 2006). Despite being 
able to produce pro-inflammatory cytokines (Park and Bowers, 2010), suppress T-cell 
activation (Tian et al., 2009) and express class I MHC molecules (Ribic et al., 2010), 
neurons are the most passive cells in the CNS immune response. On the other hand, 
microglia are the main responsible cells involved in innate immune response. These cells 
are derived from myeloid cells in the periphery and comprise approximately 12% of cells 
in the brain, being predominate in the grey matter, with the highest concentrations in the 
hippocampus, substantia nigra, basal ganglia and telencephalon (Block et al., 2007). 
Under physiological conditions, microglia has a key role in monitoring the homeostasis of 
the brain, actively surveying the brain parenchyma for the presence of an insult (Kraft and 
Harry, 2011). Thus, an important feature of neuroinflammation is microglial activation, 
(Czeh et al., 2011) and the subsequent secretion of chemokines, cytokines and 
prostaglandins providing to the CNS a first line of response to the external insults (Lucas 
et al., 2006; Farooqui et al., 2007).  
Microglia may present at least three phenotypic states: surveying ramified, 
activated non-phagocytic, and reactive, amoeboid phagocytic microglia (Figure 1.4). 
Under physiological conditions, microglia exhibit a resting ramified state, with a small 
cellular body. Despite being referred to as resting, microglia are constantly surveying the 
surrounding environment, being able to maintain homeostasis and identifying signals that 
require a response (Lull and Block, 2010). During this stage, microglia presents a 
surveying-like down-regulated immune phenotype, poor antigen presenting cells (APCs) 
with weak expression of MHC-II molecules, cytokines and their receptors, and no co-
stimulatory molecules (Frei et al., 1994). Occasionally, microglia is moderately activated 
to play the classic role as scavengers for the maintenance and restoration of the CNS. In 
response to brain insults, microglial cells are rapidly activated and their cell-surface 
receptor expression is modified, with up-regulation of surface receptors or antigen, such  
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as MHC-II and CD11b (Nakamura, 2002; Kim and de Vellis, 2005). Also, their phenotype is 
altered, cell body suffers swelling and became an amoeboid shaped cells with a 
phagocytic function. When activated, microglial cells are able to proliferate, migrate to 
the site of damage, and secrete pro- and anti-inflammatory cytokines, chemokines, stress 
inducing factors and growth factors (Hanisch and Kettenmann, 2007; Czeh et al., 2011).  
 
 
 
Figure 1.4 - Morphological changes during microglial activation. Surveying microglia is kept in stand-by 
mode to regulate CNS homeostasis. Several stimuli trigger microglia activation with antigen surface 
expression, proliferation, and migration. Transformed phagocytic microglia acquires the amoeboid shape 
and secretes various bioactive molecules, such as cytokines (adapted from Dilger and Johnson, 2008). 
 
It is important to notice that microglial activation can be either beneficial or 
harmful, depending on the damage or stress exerted to the CNS (Walter and Neumann, 
2009). Also, different pathways are activated when microglia are under a stress stimuli or 
during infection. Under bacterial invasion, a response called classically activated microglia 
(Fig. 1.5) is triggered. This response involves the expression of CD 86 and CD16/32, 
production of oxidative metabolites (NO, superoxide and hydrogen peroxide), pro-
inflammatory cytokines and proteases (Hanisch and Kettenmann, 2007; Czeh et al., 2011). 
As a consequence of this type of response, neuronal damage and reactive gliosis can be 
caused to healthy cells (Czeh et al., 2011). Kacimi and collegues perform a study with co-
cultures of endothelial and microglial cells, in which LPS-activated microglia promote BBB 
disruption through injury to endothelial cells, although in monocultures LPS induced 
microglial cell death but not endothelial cell (ECs) death (Kacimi et al., 2011). In 
alternative, after a stress insult, microglia release anti-inflammatory factors and express 
Surveying 
microglial cell 
Activated non-phagocytic 
microglial cell 
Reactive amoeboid 
phagocytic 
microglial cell 
Chapter 1 - Introduction 
29 
CD206 and arginase 1 leading to down-regulation of inflammation and tissue 
remodeling/repair (Fig. 1.5).  
 
Figure 1.5 – Classical and alternative activated microglia. Microglial cells can be classified in a simplified 
manner into subsets of phenotypes and effector functions depending on the activation pathway (adapted 
from Czeh et al., 2011). 
 
Studies from our group, showed an acute high dose of METH (30 mg⁄kg, i.p.) 
triggers an inflammatory process characterized by microglia activation and increase of 
tumor necrosis factor (TNF) levels in the  hippocampus, which was prevented by an anti-
inflammatory treatment (Gonçalves et al., 2010). More recently, using N9 cell line as an in 
vitro model, Coelho-Santos and colleagues demonstrated that METH induced microglial 
cell death and increase TNF-α and IL-6 extracellular and intracellular levels, as well as 
their receptor protein levels, at 1 h and 24 h post-exposure. Interestingly, exogenous low 
concentrations of TNF-α or IL-6 had a protective effect, suggesting a dual role for 
cytokines. Furthermore, the same study verified that activation of IL-6 signaling, 
specifically the JAK/STAT pathway, mediates the anti-apoptotic role of TNF-α, which in 
turn induced down-regulation of Bax/Bcl-2 ratio (Coelho-Santos et al., 2012) 
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1.3 JAK/STAT signaling pathway  
The Janus kinase/signal transducers and activators of transcription (JAK/STAT) 
pathway is one of a handful cascade used to transduce a multitude of signals for 
development (Kishimoto et al., 1994). In mammals, the JAK/STAT pathway is the principal 
signaling pathway for a large variety of cytokine involved in immune response but also in 
the action of and growth factors and hormones and its activation stimulates cell 
proliferation, differentiation, cell migration and apoptosis (Huang et al., 2008). 
Intracellular activation occurs when ligand binding induces the multimerization of 
receptor subunits. Depending on the ligand, the receptor subunits can be bound as 
homodimers or as heteromultimers, despite that, signal propagation through either 
homodimers or heteromultimers requires the association of cytoplasmic domains of two 
receptor subunits to JAK tyrosine kinases (Rawlings et al., 2004).  JAKs have kinase-
homologous domains at the C-terminus, while the first is a non-catalytic regulatory 
domain, the second has tyrosine kinase activity. JAK family comprises four members: 
JAK1, JAK2, JAK3 and Tyrosine kinase 2 (Tyk2; Huang et al., 2008) and its activation occurs 
upon ligand-mediated receptor multimerization because two JAKs are brought into close 
proximity, allowing trans-phosphorylation. The activated JAKs subsequently 
phosphorylate additional targets, including both the receptors and the major substrates, 
STATs witch are latent transcription factors that remain in the cytoplasm until activated. 
STATs have a conserved tyrosine residue near the C-terminus that is phosphorylated by 
JAKs (Shuai and Liu, 2003). This phosphotyrosine permits the dimerization of STATs 
through interaction with a conserved SH2 domain. Phosphorylated STATs enter the 
nucleus by a mechanism that is dependent on importin α-5 (also called nucleoprotein 
interactor 1) and the Ran nuclear import pathway (Heim, 1999). Once in the nucleus, 
dimerized STATs bind specific regulatory sequences to activate or repress transcription of 
target genes (Fig. 1.6); therefore, an initial extracellular signal is translated to a 
transcriptional response (Heim, 1999; Shuai and Liu., 2003)  
Some in vitro studies suggest the involvement of JAK/STAT pathway in microgial 
response. Kacimi and colleagues reported that inhibition of JAK/STAT improve microglial 
viability and reduce NO accumulation (Kacimi et al. 2011). Moreover, Coelho-Santos and 
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co-workers demonstrated the involvement of this signaling pathway in the prevention of 
METH-induced cell death by TNF-α and IL-6 (Coelho-Santos et al. 2012).   
 
Figure 1.6 - Schematic representation of JAK/STAT signaling pathway. The Janus kinase (JAK)–signal 
transducer and activator of transcription (STAT) pathway is regulated at many levels. JAKs can be negatively 
regulated by suppressor of cytokine signalling (SOCS) proteins, protein tyrosine phosphatases (PTPs), such 
as SRC homology 2 (SH2)-domain-containing PTP1 (SHP1), SHP2, CD45 and T-cell PTP (TCPTP), and ubiquitin-
mediated protein degradation. SOCS proteins, which are induced by cytokines, act as a negative-feedback 
loop to switch off the activity of JAKs. Many PTPs participate in the regulation of JAKs. The regulation of 
JAK2 by ubiquitylation (Ub) has also been suggested. The physiological significance of protein ubiquitylation 
in the regulation of JAKs remains to be determined. JAKs might also be regulated by other proteins, such as 
the SH2-B family of putative adaptor proteins (not shown). STATs can be negatively regulated by PTPs (such 
as PTP1B and TCPTP) in the cytoplasm, and by PIAS proteins, as well as PTPs (such as TCPTP and SHP2), in 
the nucleus. Protein inhibitor of activated STAT (PIAS) proteins interacts with STATs in response to cytokine 
stimulation and they inhibit the transcriptional activity of STATs through distinct mechanisms (Shuai and 
Liu., 2003). 
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1.4 Blood-brain barrier (BBB) 
1.4.1 Functional Anatomy 
Barrier layers at the key interfaces between neural tissue and blood play a major 
role in maintaining the homeostasis of the neural microenvironment (Sandoval and Witt, 
2008). One of these barriers is the blood-brain barrier (BBB), which consists of an 
interdependent network of cells that separate the CNS from the systemic circulation. The 
barrier function is created at the level of the cerebral capillary endothelial cells (ECs)by 
tight junction formation. BBB acts as the gate-keeper of the CNS maintaining the fragile 
homeostasis of the brain (Abbott et al., 2010) and is composed by a dynamic 
communication between neurons, microglia, astrocytes, pericytes, endothelial cells and 
extracellular-matrix (ECM), forming the neuro(glial)vascular unit (Fig. 1.7) (Hawkins and 
Davis, 2005). Brain endothelial cells , localized between blood and brain, play an 
important role in transport of micro and macronutrients, receptor-mediated signaling, 
leukocyte trafficking and osmoregulation (Persidsky et al., 2006). ECs cytoplasm has 
uniform thickness with no fenestrae, low pinocytotic activity and continuous basement 
membrane (Boer and Gaillard, 2006). Another structural characteristic is the great 
number of mitochondria, providing energy for enzymes to break down compounds and 
allowing diverse selective transport systems to actively transport nutrients and other 
compounds into and out of the brain (Cardoso et al., 2010). 
 
Chapter 1 - Introduction 
33 
 
Figure 1.7 - Schematic representation of the neuro(glial)vascular unit. The cerebral endothelial cells have 
intercellular junctions that confer the barrier property of the BBB.  Pericytes are distributed discontinously 
along the length of the cerebral capillaries. Both the cerebral endothelial cells and the pericytes are 
enclosed  by,  and  contribute  to,  the  local  basement  membrane  which  forms  a  distinct  perivascular  
extracellular matrix (basal lamina 1, BL1), different in composition from the extracellular matrix  of the glial 
endfeet bounding the brain parenchyma (BL2). Foot processes from astrocytes form a complex network 
surrounding the capillaries. Axonal projections from neurons contain vasoactive neurotransmitters that 
regulate local cerebral blood. Microglial cells have an immunovigilant function in the barrier (Abbott et al., 
2010).  
 
BBB is characterized by the presence of an elaborated junctional complex that 
includes tight junction (TJ) and adherens junction (AJ) proteins. TJs include 
transmembrane proteins [claudins, occludin and junctional adhesion molecules molecules 
(JAMs)] and intracellular proteins such as zona occulens (ZO)-1, -2 and -3. ZO are 
accessory proteins linking TJ membrane proteins to the actin cytoskeleton (Hawkins and 
Davis, 2005). The AJs hold the cells together giving the tissue a structural support. 
Cadherin proteins cross the intercellular cleft and are linked into the cell cytoplasm by the 
scaffolding proteins α, β and γ catenin (Fig. 1.8). Both TJs and AJs are essential for barrier 
properties and alterations of these proteins may lead to BBB dysfunction (Persidsky et al., 
2006; Cecchelli et al., 2007).   
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Figure 1.8 - Structure of BBB complex junctions. The tigh junctional complex comprises junctional adhesion 
molecules (JAMs), occludin and claudins. The claudins and occludin are linked to the scaffolding proteins ZO 
which in turn are linked via cingulin dimers to the actin/myosin cytoskeleton within the cell In the adherens 
junctions (AJs), VE-cadherin proteins are linked to the actin cytoskeleton by the scaffolding proteins catenin 
(Abbott et al., 2010). 
Despite the name barrier, BBB is a dynamic structure allowing the passage of 
several molecules via different routes of transport across the endothelial cells. The TJs 
confer to the BBB a highly impermeability to paracellular transport (Fig. 1.9a) through the 
junctions, forcing a transcellular route across the BBB (Abbott, 2006). Small gaseous 
molecules, such as molecular oxygen (O2) and carbon dioxide (CO2) can diffuse through 
lipid membranes, and this is also a route of entry for small lipophilic agents (Fig. 1.9b). 
The presence of specific transport systems on the luminal and abluminal membranes 
regulates the transcellular traffic of small hydrophilic molecules (Fig. 1.9c). Additionally, 
large molecules, such as peptides and proteins are transported by specific receptor-
mediated transcytosis (Fig. 1.9d) or by the less specific adsorptive-mediated transcytosis 
(Fig. 1.9e) (Abbott et al., 2006).   
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Figure 1.9 - Transport mechanisms at the blood-brain barrier. The paracellular transport is important for 
ionic homeostasis.  The presence of specific transporters and transcytosis are essential to suppress the 
nutritional needs of the brain parenchyma.  Nevertheless, transcytosis occur at a low level under 
physiological conditions (Abbott et al., 2006). 
 
1.4.2 Alterations of BBB function caused by METH 
METH is a lipophilic molecule and a weak base, with low molecular weight and low 
protein binding capacity, allowing an easy diffusion across plasma membranes and lipid 
layers as BBB. After crossing BBB, METH activates an immediate signaling cascade that 
result in the release of monoamines (Martins et al., 2011). However, METH has also a 
direct effect on BBB function. Recent studies have demonstrated the effects of METH on 
the BBB and a possible relationship to METH toxicity. In fact, it is already known that 
METH disrupts the BBB in several brain regions including the cortex, hippocampus, 
thalamus, hypothalamus, cerebellum, amygdala and striatum (Krasnova and Cadet, 2009). 
Specifically, Sharma and Kiyatkin showed increased BBB permeability using Evans blue 
and by leakage of serum albumin into the brain tissue in rats. An elevated brain 
temperature may also cause the breakdown of the BBB, resulting in brain edema, 
astrocytic activation and alterations of the CNS microenvironment (Sharma and Kiyatkin, 
2009). Indeed, mild BBB dysfunction found in the caudate-putamen after METH 
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treatment was exacerbated by hyperthermia (Dietrich, 2009). Martins and colleagues also 
verified an increase in BBB permeability 24 h after administration of an acute high dose of 
METH, which was a transient effect since 72 h post-METH administration no leakage of 
Evans Blue was detected (Martins et al., 2011).  
In an attempt to understand the mechanisms responsible for METH-induced BBB 
dysfunction, Ramirez and colleagues demonstrated that METH compromises the barrier 
at the level of tight junctions. Microscopy analysis of immuno-fluorescence-labeled 
occludin and claudin-5 of primary brain endothelial cells (BMVEC) exposed to METH 
reveled low occludin and claudin-5 staining and gap formation (Ramirez et al., 2009). 
Occludin, but not claudin-5, followed a time dependent decrease in expression (Ramirez 
et al., 2009). Martins and colleagues confirm the previous results and also demonstrated 
a decrease in ZO-1 expression in the hippocampus, which can explain the increased BBB 
permeability. Furthermore, brain endothelial glucose transporter is also involved in BBB 
dysfunction (Martins et al. 2011). Recent data indicate that high concentration of METH 
decreased both the glucose uptake and glucose transporter 1 (GLUT1) protein levels in 
human brain endothelial cells (hBEC) culture. METH-induced decrease in GLUT1 protein 
level was associated with reduction in BBB tight junction protein occludin and ZO-1. 
Functional assessment of the trans-endothelial electrical resistance of the cell monolayers 
and permeability of dye tracers validate the pharmacokinetics and molecular findings that 
inhibition of glucose uptake by GLUT1 inhibitor cytochalasin B (CB) aggravated the METH-
induced disruption of the BBB integrity (Muneer et al., 2011).  
Multiple studies suggest that METH-induced neurotoxicity involves oxidative stress 
(Yamamoto et al., 2010). Ramirez and collaborators demonstrated that METH induced 
ROS in primary brain endothelial cells, decreased expression of TJ proteins and increased 
BBB permeability, although antioxidants prevented the production of oxidative radicals 
and restored monolayer integrity. The antioxidant Trolox prevented the increased 
permeability caused by METH (Ramirez et al., 2009). Other key players are the 
metalloproteinases (MMPs) that can degrade tight junction proteins. In fact, METH 
increases the levels of MMP-9 and MMP-1, and amphetamine mediated oxidative stress 
is followed by activation of MMPs and breakdown of tight junction, which in turn leads to 
BBB disruption (Yamamoto et al., 2010). Martins and colleagues, demonstrated an 
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increase in MMP-9 activity and immunoreactivity after 24 hours, at the hippocampus, 
correlated with decrease in TJ protein levels and BBB disruption. These results suggest 
that the increased activity and expression of MMP-9 is related with the decrease of 
claudin-5, occludin and ZO-1 expression and BBB disruption (Martins et al., 2011). 
Furthermore, Urrutia and colleagues reported that inhibition of JNK pathway prevented 
METH-induced changes in MMP-9 activity, laminin degradation and BBB leakage (Urrutia 
et al., 2013). Very recently, using brain microvascular endothelial cells (BMVECs), it was 
reported that NO is involved in METH-induced transcytosis (Martins et al., 2013).  
 
1.5 Role of inflammatory mediators in METH-induced brain dysfunction 
1.5.1 Nitric oxide  
NO, a small radical molecule, was identified in biological systems as an important 
intercellular gas messenger present in the cardiovascular, immune and nervous systems 
(Culotta, 1992). In brain, NO plays a dual action, being involved in physiological and 
pathological processes. It is implicated in the modulation of neuronal function such as 
synaptic plasticity (Prast and Philippu, 2001) and regulation of blood flow (MacMicking et 
al., 1997). However, NO is also associated with neurodegenerative diseases and 
inflammation (Reis, 2006; Pacher et al., 2007). 
NO is produced in vivo by nitric oxide synthase (NOS), a highly regulated enzyme 
that uses L-arginine (L-arg) and O2 as substrates (Palmer et al., 1988).Garthwaite and 
collaborators demonstrated that activation of glutamatergic receptors, particularly the 
NMDA subtype, induces NO synthesis from L-arg in rat brain slices (Garthwaite et al., 
1988, 1989). This observation led to NOS cloning and isolation in the brain, where it was 
shown to be expressed by a number of different cells and regions (Bredt et al., 1990, 
1991; Schmidt et al., 1991). Since this was the first NO synthase to be identified it was 
named NOS1 or neuronal NOS (nNOS), because it is typically expressed by neurons. 
Afterwards, a second isoform was isolated from macrophages and termed NOS2 or 
inducible NOS (iNOS; Hevel et al., 1991; Stuehr et al., 1991) because it could be readily 
induced by proinflammatory cytokines (Busse et al., 1990; Radomski et al., 1990) and is 
expressed in many cell types (such as endothelial and microglial cells). The first source of 
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NO identified, the endothelial NO synthase (NOS3 or eNOS) was the first to be identified 
but the last to be cloned and it is present in endothelial cells (Pollock et al., 1991). These 
isoforms can also be divided according to their expression, being termed constitutive 
(nNOS and eNOS) because they are always present in a large cellular populations, or 
inducible (iNOS), as its expression depends largely on immunologic or inflammatory 
stimulus. Another major difference is that the latter is largely Ca2+-independent (Busse et 
al,. 1990), whereas the former are not (Stuehr et al., 1991). Importantly, iNOS gene has a 
STAT binding site in their promoter region (Kim et al., 2008).  
During the synthesis of NO by NOS, electrons from nicotinamide adenine 
dinucleotide phosphate (NADPH) flow between subunits to activate O2 at the heme 
group, where L-arg is used to generate NO, L-citrulline and H2O (Fig. 1.10, A). The enzyme 
converts the guanidino nitrogen of L-arg to NO and L-citrulline in a process that consumes 
five electrons (Bredt et al., 1994) and requires it to cycle twice. In the first step, NOS 
consumes one mol of NADPH to hydroxylate L-arginine to Nω-hydroxyl-L-arginine, which 
is an enzyme-bound intermediate (Stuehr et al., 1991). In an unusual second step, one 
electron from NADPH and another from Nω-hydroxyl-L-arginine lead to oxygen 
incorporation and scission of the C-N bond, yielding citrulline and NO (Fig. 1.10B; Stuehr 
et al., 1991). 
 
Figure 1.10 - Synthesis of NO by NOS. A) The guanidine nitrogen of L-arg is converted to NO in a two steps 
reaction at the heme group of NOS dimer. B) Partial reactions to form NO. Adapted from (Alderton et al., 
2001) and (Stuehr et al., 2001).  
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NO can mediate a number of reactions by itself or it can also react with other 
molecules. We have shown that METH increased the activation of eNOS in rat endothelial 
cells, being involved in the transcytosis mediated by METH (Martins et al., 2013). 
Additionally, there are several reports in the literature discussing the involvement of 
superoxide radicals (O2
.-) in METH-induced neurotoxicity (Cadet and Brannock, 1998). It 
has been reported that METH-induced dopaminergic depletion is attenuated in copper-
zinc superoxide dismutase (CuZn-SOD) overexpressed transgenic mice (Cadet et al. 1995). 
Previously, we also referred that NO metabolism can contribute to oxidative stress 
induced by METH (Itzhak and Ali, 2006). Wang and Angulo demonstrated an up-regulation 
of neuronal nitric oxide synthase (nNOS) and 3-NT in mice striatum, using an acute METH 
administration (30 mg/kg, i.p.; Wang and Angulo, 2011). So, O2
.- and NO interaction 
results in ONOO- formation, which plays a major role in METH-induced dopaminergic 
neurotoxicity. Because of its high reactivity under physiological conditions, direct 
measurement of ONOO- in vivo is not achieved easily. However, the nitration of tyrosyl 
residues has been shown to be a stable biochemical marker of ONOO- production both in 
vitro and in vivo (Beckamn et al., 1994; Ischiropoulos, 1992). 3-NT results from the 
induction of nitration of tyrosine residues by ONOO-, therefore 3-NT is a good indicator of 
peroxynitrite damage (Dijkstra et al., 1998).  
 
1.5.2 Reactive oxygen species 
ROS are oxygen-containing molecules that react with and oxidize vulnerable 
cellular constituents, such as proteins, nucleic acids and lipids (Kraft and Harry, 2011). 
ROS are produced intracellularly through multiple mechanisms, mainly in the 
mitochondria, peroxisomes, endoplasmic reticulum, and the NADPH oxidase (NOX) 
complex in cell membranes (Muller, 2000). In eukaryotic cells the majority of energetic 
needs, ATP, is obtained by mitochondrial oxidative phosphorylation (OXPHOS), a process 
by which the oxidoreduction energy of mitochondrial electron transport is converted to 
the high-energy phosphate bond of ATP, which requires 4 supramolecular complexes of 
the respiratory chain and ATP-synthase. O2 is the final electron acceptor for cytochrome-c 
oxidase (complex IV), the terminal enzymatic component of this mitochondrial enzymatic 
complex responsible for the four-electron reduction of O2 to H2O (Kocherginsky, 2009). 
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Partially reduced and highly reactive metabolites of O2 may be formed during these (and 
other) electron transfer reactions. These O2 metabolites include superoxide anion (O2
-.) 
and hydrogen peroxide (H2O2), formed by one- and two-electron reductions of O2, 
respectively. When transition metal ions are present, the even more reactive hydroxyl 
radical (OH-) can be formed. These partially reduced metabolites of O2 are often referred 
to as ROS due to their higher reactivity relative to molecular O2 (Dikalov, 2011).  
Microglia are a robust source of free radicals which can induce neuronal damage, 
and NADPH oxidase (membrane-bound enzyme that catalyses the production of 
superoxide from oxygen) is implicated as both the primary source of microglial-derived 
extracellular ROS and a mechanism of pro-inflammatory signalling in microglia (Babior, 
1999). NADPH oxidase is activated by various stimuli, including bacterial PAMPs, 
inflammatory peptides and multiple neurotoxins. Several pattern recognition receptors 
(PRRs) activate NADPH oxidase, but the MAC1 receptor might be crucial for microglial 
NADPH oxidase activation in response to neurotoxic stimuli (Fig. 1.11). In resting cells, 
NADPH oxidase is composed of several subunits, and the cytosolic subunits (p47, p67, p40 
and Rac2) are distributed between the cytosol and the membranes of intracellular 
vesicles and organelles (Babior, 1999). When microglia are activated, the cytosolic 
subunits translocate to membranes, where they bind to the membrane-associated 
subunits (p22 and gp91) and assemble the active oxidase to produce extracellular 
superoxide (Block et al., 2007).  
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Figure 1.11 - Microglial PRRs identify neurotoxic and pro-inflammatory ligands. Microglia actively monitor 
the brain environment with pattern recognition receptors (PRRs). PRRs are responsible for several 
phagocytic functions such as the identification of pathogens, the production of extracellular superoxide, the 
release of pro-inflammatory compounds and the removal and destruction of toxic stimuli through 
internalization and phagocytosis (Block et al., 2007) 
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1.6 Objectives 
The impact of METH on the CNS has been extensively study, and the involvement of 
nitrosative and oxidative stress are some of the mechanisms responsible for METH-
induced neurotoxicity. Nevertheless, many questions remain unanswered particularly 
regarding the direct effect of METH on microglial and endothelial cells. In fact, the 
majority of the hypotheses focused on neuronal events.  
Therefore, the aim of the present work was to evaluate the inflammatory process 
triggered by METH on both microglial and endothelial cells, looking particularly for 
nitrosative and oxidative responses. For that, we performed a concentration- and time-
dependent study to evaluate the alterations on nitrites, 3-nitrotyrosine and ROS levels. 
Cell viability was also analyzed. 
Knowing that METH consumption is a serious worldwide health problem, and that 
induces brain dysfunction including neuropsychiatric disorders, it is crucial to understand 
its effect on the CNS.  
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Chapter 2 
Material and methods 
 
Cell culture  
2.1.1 N9 cell line 
The murine microglia cell line N9 (kindly provided by Prof. Claudia Verderio, CNR 
Institute of Neuroscience, Cellular and Molecular Pharmacology, Milan, Italy) was 
developed by immortalizing primary microglia cells with the v-myc or v-mil oncogenes of 
the avian retrovirus MH2 (Righi et al., 1989). N9 microglial cells were cultured in RPMI 
(Gibco, Paisly, UK) supplemented with 5% fetal bovine serum (FBS; Gibco), 23.8 mM 
sodium bicarbonate (Sigma-Aldrich, St. Louis, MO, USA), 30 mM D-glucose (Sigma-
Aldrich), 100 U/ml penicillin and 100 μg/ml streptomycin (Gibco). Cells were kept at 37oC 
in a 95% atmospheric air and 5% CO2 humidified incubator (Thermo Scientific Forma 
Series II, Marietta, USA) and grown in 75 cm2 tissue flasks. Before plating cells for the 
different experimental procedures, the number of viable cells was evaluated by counting 
trypan-blue excluding cells with a hemocytometer cell counting chamber and plated at 
the densities indicated in Table I, according to the different experimental procedures.   
 
Table I. Cell densities used to plate microglial cells according to the experiment. 
Experiment Nº cells/well Multiwell 
culture plate 
Medium 
volume 
Final 
concentration 
MTT assay 12000 96 150 μl 80000 cells/cm2 
Griess assay 40000 24 500 μl 80000 cells/cm2 
Immunocytochemistry 80000 12 1000 μl 80000 cells/cm2 
H2DCFDA 12000 96 150 μl 80000 cells/cm
2 
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2.1.2 bEnd.3 cell line 
The mouse brain endothelial cell line bEnd.3, originally generated in 1990 
(Montesano et al., 1990), was obtained from American Type Culture Collection (ATCC; 
Manassas, VA, USA). Cells were cultured in ATCC-formulated Dulbecco’s Modified Eagle’s 
Medium (DMEM; Gibco, UK) supplemented with 10% FBS (Gibco, Rockville, MD, USA), 
100 U/ml penicillin, and 10 µg/ml streptomycin (Gibco). Cells were grown in 25 cm2 tissue 
flasks and were maintained in a humidified cell culture incubator at 37oC and 5% CO2/95% 
atmospheric air. Before plating cells for the different experimental procedures, the 
number of viable cells was evaluated by counting trypan-blue excluding cells with a 
hemocytometer cell counting chamber. For all experiments cells were used in passage 26-
34 and plated at the density of 2x104cells/cm2 and were allowed to reach confluence 
within 5-7 days and were used 3 days after reaching confluence. For all experiments, cells 
were in passage 26-34 and plated at a density of 2 x 104cells/cm2.  
 
2.2 Griess assay 
Production of NO was determined through the formation and accumulation of its 
stable metabolite product, nitrite (NO2
-), using a colorimetric assay, the Griess assay. 
According to the Griess reaction, under acidic conditions nitrite reacts with the amino 
group of sulfanilamide to form the diazonium cation, which couples to N-(1-
naphthyl)ethylenediamine to form the corresponding red–violet coloured azo dye, with a 
maximum wavelength of 540 nm (Tsikas, 2007).  
N9 cells were treated with METH [(+)-Methamphetamine hydrochloride, Sigma, 
USA; in μM: 1, 10 or 100] or 1 μg/ml LPS for 1, 4 and 24 h (Fig. 2.1), whereas bEnd.3 cells 
were treated with 250 μM, 1 mM, 3 mM METH or 1 μg/ml LPS for 1, 4 and 24 h (Fig. 2.2). 
Also, 1 mM L-NG-Nitroarginine methyl ester (L-NAME) was used as a pretreatment, 
during one hour, before incubation with 1 μM METH in N9 cells or 250 μM METH in 
bEnd.3 cells (Fig.2.1; Fig. 2.2). METH, LPS and L-NAME were diluted in Krebs solution [142 
mM NaCl, 4 mM KCl, 1 mM MgCl2.6H2O, 1 mM CaCl2.2H2O, 10 mM Glucose, 10 mM HEPES 
(4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), pH 7.4]. Furthermore, to investigate 
if JAK/STAT pathway is involved in nitrite release induced by METH in N9 cells, we used 20 
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μM tyrphostin AG 490 (AG 490; Fig. 2.3), which inhibits the activation of STAT3 (Gorina et 
al., 2007).  
After treatments, 100 μl of supernatant was collected from wells and transferred 
to a 96-multiwell. Then, 100 μl of Griess reagent (1% sulfanilamide and 0.1% N-
naphthylethyl-ethylenediamine dihy-drochloride in 5% phosphoric acid were mixed at a 
ratio of 1:1), was added to the calibration curve and samples. After 10 min of incubation, 
in the dark and at room temperature (RT), the nitrite released into the medium was 
quantified using a standard curve (performed in Krebs solution), obtained by serial 
dilutions of 4 mM sodium nitrite (NaNO2; 0-200 μM). Absorbance was measured at 540 
nm (reference 620 nm) on the SynergyTM HT multi-detection microplate reader (BioTek, 
Windoski, USA). The concentrations of sodium nitrite in control and exposed cells were 
plotted against the standard curve.  
 
Figure 2.1 - Representation of the experimental design protocol used to investigate nitrite release in N9 
cells. Cells were exposed to 1, 10, 100 μM METH or 1 μg/ml LPS during 1 h, 4 h or 24 h. Cells were also pre-
treated during 1 h with 1 mM L-NAME and then co-exposed with 1 μM METH. 
 
Figure 2.2 - Representation of the experimental design protocol used to investigate nitrite release in bEnd.3 
cells. Cells were exposed to 250 μM, 1, 3 mM METH or 1 μg/ml LPS. Cells were also pre-treated during 1 h 
with 1 mM L-NAME and then co-exposed with 250 μM METH. 
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Figure 2.3 - Representation of the experimental design protocol used to investigate JAK/STAT pathway 
involvement in nitrite release by N9 cells. Cells were exposed to 1 μM METH. Cells were also pre-treated 
during 1 h with 20 μM AG490 and then co-exposed with 1 μM METH. 
 
2.3 MTT assay 
The reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide 
(MTT, yellow colored) to tetrazole was used to evaluate cell viability. This is a colorimetric 
assay in which MTT is reduced by metabolically active cells to insoluble purple formazan 
dye crystals. The rate of tetrazolium reduction is proportional to the rate of mitochondrial 
enzyme succinate dehydrogenase activity (Mosmann, 1983). 
N9 cells were plated in 96-wells culture plates, allowed to grow until reach 
confluence and then incubated with METH for 1, 4 and 24 h. 
The bEnd.3 cells were seeded on a 96–multiwell plate and were allowed to grown 
until reach confluence and then incubated with a concentration of 1 or 3 mM METH for 1, 
4 and 24 h.  
After treatments, the medium was removed and the cells were washed with Krebs 
solution and 0.5 mg/ml MTT solution was added to each well and cells were kept at 37oC 
in a 95% atmospheric air and 5% CO2 humidified incubator (Thermo Scientific Forma 
Series II) for 3 hours. The crystals were then dissolved in dimethyl sulfoxide (DMSO) with 
vigorous resuspension. The resulting purple needle-shaped crystals were dissolved by the 
addition of acidic isopropanol (0.04 M HCl in absolute isopropanol). To completely 
solubilize the crystals, repetitive pipetting was applied and the plate was stirred on an 
automatic plate shaker in the dark at RT. Absorbance was measured at 570 nm (reference 
620 nm) on the SynergyTM HT multi-detection microplate reader (BioTek).  
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2.4  Immunocytochemistry  
Double-labeling immunofluorescence was performed for 3-NT and a microglial 
marker, CD11b. Briefly, cells were exposed to 1 μM METH for 1 h or pretreated during 1 h 
with 1 mM L-NAME and then co-exposed with 1 μM METH for one more hour (Fig. 2.4). A 
positive control was also performed exposing cells to 10 mM NaNO2. After treatments, 
cells were rinsed with PBS, fixed with ethanol:acetic acid [95:5] for one minute at RT, 
washed with PBS and blocked with a solution of 1% BSA in PBS for 30 min. Afterwards, 
cells were incubated with rabbit anti-mouse 3-NT antibody (1:100; Millipore, Billerica, 
MA, USA), in PBS with 1% BSA, 40C overnight (ON). After washed, cells were incubated 
with the secondary antibody Alexa Fluor 488 (1:200; Invitrogen, Inchinnan Business Park, 
UK) for 1 h 30 min at RT and from this point forward cells were protected from light. Cells 
were again washed and blocked with 1% BSA in PBS for 30 min, and incubated with rat 
anti-mouse CD11b antibody (1:500; AbD Serotec, Oxford, UK) for 3 h at RT. After the 
incubation, cells were washed one more time and incubated with Alexa Fluor 594 (1:200; 
Invitrogen) for 1 h 30 min RT. The cells were then washed and stained with 4 µg/ml 
Hoechst 33342 for 5 min at RT in the dark. Finally, cells were washed and mounted in 
DakoCytomation fluorescent medium and stored in dark at 4oC until examined in a LSM 
710 Meta confocal microscope (Carl Zeiss, Göttingen, Germany). 
 
Figure 2.4 - Representation of the experimental design protocol used to investigate 3-NT immunoreactivity 
in N9 cells. Cells were exposed to 1 μM METH and also pre-treated during 1 h with 1 μM L-NAME and then 
co-exposed with 1 μM METH.  
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2.5 Detection of intracellular levels of reactive oxygen species (ROS)  
Intracellular levels of ROS can be detected by fluorimetry, using 
dichlorofluorescein (H2DCFDA) probe. H2DCFDA is able to cross the cell membrane and 
their acetate groups are removed by intracellular esterases, producing H2DCF. H2DCF 
reacts with several cytotoxic oxygen species producing 2',7'-dichlorofluorescein (DCF) that 
can be used as a measure of intracellular ROS levels (NEVŘELOVÁ et al., 2005). 
Microglial cells were plated on black 96-multiwells, and METH (1, 10 and 100 μM) 
or 1 μg/ml LPS were added for 1, 4 and 24 h. bEnd.3 cells were also plated on black 96-
multiwells and after reaching confluence, cells were exposed to METH (250 μM, 1 and 3 
mM) or 1 μg/ml LPS for 1, 4 and 24 h. Immediately after treatments, medium was 
removed and cells were incubated with 5 μM H2DCFDA diluted in PBS (in dark conditions) 
and kept at 37oC in a 95% atmospheric air and 5% CO2 humidified incubator (Thermo 
Scientific Forma Series II, Marietta, USA). The excitation and emission filters used for the 
H2DCFDA probe were 485/20 nm and 528/35 nm respectively. The value after bar 
indicates slip values used. 
 
2.6 Statistical analysis 
Statistical analysis was performed using GraphPad Prism 5.0 (GraphPad Software, 
San Diego, CA). Statistical significance was considered relevant for P<0.05 using one-way 
analysis of variance followed by Dunnett´s post hoc test for comparison with control 
condition, followed by Bonferroni´s post hoc test for comparison among experimental 
conditions. In MTT studies performed with b.End3 cell line, statistical significance was 
determined using two-tailed student t-test. Data were presented as mean±SEM (standard 
error of the mean). To normalize results between experiments, the results of each 
experiment were expressed as the percentage of control. 
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Results 
3.1 Methamphetamine-induced production of nitrites by microglial and 
endothelial cells 
Microglial activation, a crucial feature of the inflammatory response in the CNS, is 
characterized by the release of inflammatory mediators such as cytokines, NO and 
prostaglandins (Huo et al., 2011; Kamici et al., 2011). Regarding drugs of abuse, Sekine 
and colleagues demonstrated microglial activation in human brain of METH abusers 
(Sekine et al., 2008), furthermore results from our group also showed that METH triggers 
a microglial response in the mice hipoccampus (Gonçalves et al., 2010).  
In the present study, we aimed to evaluate if METH induces the release of nitrites 
by microglial cells. For that, we used the N9 cell line and the griess assay. Cells were 
exposed to METH (1, 10 or 100 μM) during 1, 4 or 24 h. LPS (1 μg/ml), synthesized by 
gram negative bacteria, was used as an inflammatory insult since it is a complex 
macromolecule containing a polysaccharide group covalently linked to a unique lipid 
structure (Block et al., 2007). In fact, LPS is widely used to activate several inflammatory 
signaling cascades, including the secretion of proinflammatory cytokines by microglial 
cells (Burguillos et al., 2011). Here, we observed that 1 h after 1 μM METH administration 
(Fig. 1A) there was a significant release of nitrites (180.83+10.90% of control; ***P<0.001, 
n=24), which was completely abolished in the presence of 1 mM L-NAME (1 mM L-NAME 
+ 1 μM METH: 93.08±8.90% of control, +++ P<0.001, n=18), a non-selective NOS inhibitor. 
Additionally, 1 μg/ml LPS also triggered the release of nitrites (151.19±9.17% of control, 
**P<0.01, n=10) when compared to the control (100.0±6.48%, n=13). Higher 
concentrations of METH or L-NAME did not lead to differences when compared to the 
control (10 μM METH: 101.28±6.17% of control; n=18; 100 μM: 96.84±12.35% of control, 
n=7; L-NAME: 98.65±5.56% of control, n=27). Furthermore, after 4h (Fig. 1B) or 24 h (Fig. 
1C) we did not observe any significant differences when compared to the control, after 
METH treatment, showing that METH triggers a response of microglial cells within 1h and 
then returning to basal conditions. However, LPS induced a significant increase in nitrites 
Chapter 3 - Results 
52 
levels at 24 h (158.59±10.05, **P<0.01, n=5) and a tendency to increase nitrite levels, 
although not significant, at 4 h (121.56±1.94, n=6). Importantly, all the METH 
concentrations used did not induced cell death (Coelho-Santos et al., 2012). 
 
Figure 3.1 - Release of nitrites in N9 cell line after (A) 1 h, (B) 4h or (C) 24h of METH exposure. The results 
are expressed as mean percentage of control (±SEM) n=4-27. **P<0.01; ***P<0.001, significantly different 
from control using Dunnett´s post-test. +++P<0.001, significantly different from 1 μM METH using 
Bonferroni´s post-test. 
 
Recent studies showed that an up-regulation of nitrate lead to the accumulation 
of 3-nitrotyrosine (3-NT) in mice striatum (Wang and Angulo, 2011). Moreover, in the 
A 
C C 
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present work, we demonstrated an increase in nitrite levels at 1h after 1 μM METH 
exposure (Fig. 3.1A). Thus, we also performed immunocytochemistry studies to 
corroborate our results. In fact, we were able to clearly show an increase in 3-NT 
immunoreactivity and as a positive control we used 10 mM sodium nitrite (Fig. 3.2). 
 
Figure 3.2 - METH increases 3-nitrotyrosine expression. Representative confocal images of 3-NT (green) and 
CD11b (red) immunoreactivity in N9 microglial cells under control conditions, exposure to 1 μM METH, 1 
μM METH pretreated with 1 mM L-NAME or to 10 mM sodium nitrite. Cells were stained with Hoechest 
3342 (blue). Scale bar 20 μm or 5 μm (crop).  
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JAK-STAT cascade is an essential inflammatory signaling pathway that mediates 
immune and inflammatory response (Park et al., 2003; Dziennis and Alkayed, 2008). 
Binding of ligands to its receptors induces the phosphorylation of receptor-associated 
JAK, which in turn leads to STAT phosphorylation. After phosphorylation, STAT forms 
dimers and translocates into the nucleus to regulate the transcription of target genes 
encoding proinflammatory cytokines, chemokines and inducible enzymes such as iNOS 
and Cox-2 (Ganster et al., 2001; Kovarik et al., 2001). AG 490 belongs to the tyrphostin 
family of tyrosine kinase inhibitors and has been  used  to  selectively  block  the  
JAK/STAT3  signaling  pathway  and  to  inhibit  the activation of STAT3 in microglia cells 
(Kim et al., 2002; Zhu et al., 2008). 
Prompted by these findings, we use AG 490, a JAK-STAT inhibitor to further 
identify underlying mechanisms involved in nitrites release induced by METH in microglial 
cells. Here, cells were pre-treated during 1 h with 20 µM AG 490 and then co-exposed 
with 1 μM METH for 1 h. We observed that AG 490 blocked the increase in nitrite release 
induced by METH, when compared with METH alone (117.23±18.83% of control, ++ 
P<0.01, n=7) indicating that activation of JAK-STAT pathway is involved in increased levels 
of nitrite release induced by METH (Fig.3.3).  
 
Figure 3.3 - JAK/STAT inhibition blocked nitrite release triggered by 1 μM METH in N9 cell line. The results 
are expressed as mean percentage of control (±SEM) n=3-9. **P<0.01, significantly different from control 
using Dunnett´s post-test. ++P<0.01, significantly different from 1 μM METH using Bonferroni´s post-test.  
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It is already well established that METH induces BBB dysfunction (Mahajan et al., 
2008; Ramirez et al., 2009; Martins et al., 2011; Urrutia et al., 2013.). Additionally, among 
the features of METH toxicity there is the production of RNS such as NO (Quinton and 
Yamamoto, 2006), and it has already been implicated in increased BBB permeability. 
Yamagata and co-workers related NO-mediated increased permeability with changes in 
the expression of TJ proteins and a redistribution of AJ proteins, pointing to a role of NO 
in signal transduction cascades induced by hypoxia that leads to junctional 
disorganization and BBB breakdown (Yamamoto, et al.2004). Taking this information into 
account, we further aimed to clarify if METH also triggers the release of nitrites by 
endothelial cells, using for that the bEnd.3 cell line. Griess assay was performed at 1, 4 
and 24 h post-METH, and results showed that at 1 h there was a significant decrease of 
nitrites induced by 3 mM METH (48.03±3.67% of control, ***P<0.001, n=9; Fig. 3.4A). 
Nevertheless, in the presence of 250 μM METH there was a significant increase in the 
release of nitrites (130.70± 5.01% of control, *P<0.05, n= 14) which was significantly 
prevented by L-NAME pretreatment (METH + L-NAME: 87.23±6.18% of control, 
***P<0,001 n=13). 
Furthermore, 4 h after METH treatment (Fig. 3.4B) there was a significant 
difference when compared to the control with 3 mM METH (60.07±1.66% of control, 
**P<0.01; n=17). However, 24 h after METH treatment (Fig. 3.4C) a significant decrease in 
nitrites was observed with 1 mM or 3 mM METH (59.29±7.70% or 61.85±6.43%, 
**P<0.01, n=4 or n=5).  
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Figure 3.4 - Nitrites production by endothelial cell line bEnd.3 induced by METH at (A) 1 h, (B) 4 h and (C) 24 
h. METH (3 mM) significantly decreased nitrites production. The results are expressed as mean percentage 
of control (±SEM), n=4-20. **P<0.01, ***P<0.001; significantly different from control using Dunnett´s post-
test.  +++P<0.001, significantly different from 1 μM METH using Bonferroni´s post-test. 
 
3.2 Effect of METH on endothelial and microglial cell viability 
We have previously in this study showed that METH leads to an increase in nitrite 
levels, 1 h after METH treatment, with no significant alterations at other time points.  
C 
A 
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Thus, to clarify if the increased levels of nitrites could be related with cell 
alterations, we further evaluated the viability of microglial cells at the three time-points 
previously evaluated, when exposed to 1, 10 or 100 μM METH.  
Although, our study show that METH concentrations used, at the previously 
studied time points, are not able to induce any alteration on N9 cells viability (Fig. 3.5). 
 
Figure 3.5 - METH exposure during (A) 1 h, (B) 4 h and (C) 24 h did not lead to an alteration in N9 viability. 
The results are expressed as mean percentage of control ± SEM; n= 3-9. 
Concerning endothelial cells, it was shown that METH induces several deleterious 
effects at the BBB. In fact, some authors observe BBB disruption on brain regions such as 
cortex , hippocampus (Kiyatkin and Sharma, 2009) and caudate-putamen (Bowyer and Ali, 
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2006). Also, others clearly demonstrated that METH directly affects ECs (Ramirez et al., 
2009; Martins et al., 2013). Thus, to clarify if the decreased levels of nitrites could be 
related with cell alterations, we further evaluated the viability of endothelial cells at the 
three time-points, when exposed to 1 mM METH (Fig. 3.6A) or 3 mM METH (Fig. 3.6B). 
Our results reveal a significant decrease in cell viability at 24 h with 1 mM METH 
(68.24±3.69% of control, **P<0.01, n=9) and also a significant decrease with 3 mM METH 
at 1, 4 and 24 h (63.85±5.99% of control, *P<0.05, n=7; 56.94±2.46% of control, **P<0.01, 
n=9 and 45.69±4.91% of control, ***P<0.001, n=9, respectively).  
 
Figure 3.6 - Time-dependent effect of (A) 1 mM METH or (B) 3 mM METH on bEnd.3 cell viability. Cells were 
exposed to 3 or 1 mM METH for 1 h, 4 h and 24 h. The results are expressed as mean percentage of control 
(±SEM), n=3-9. *P<0.05;**P<0.01; ***P<0.001, significantly different from control using t-test. 
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3.3 METH-induced ROS production by endothelial and microglial cells 
Microglial cells are the main cellular regulators of CNS homeostasis, and after an 
injury, microglia is rapidly activated, leading to the production of several ROS (Block et al., 
2007; Kraft and Harry, 2011). Since ROS are an important element in METH toxicity 
(Krasnova and Cadet, 2009), we further aimed to investigate if METH was able to trigger 
the production of ROS. For that, we used a fluorescent probe, H2DCFDA. Different time 
points (1, 4 and 24 h) and different concentrations (1 μM, 10 μM and 100 μM METH) 
were used to cover a wide range of possible alterations.  
Data obtained for 1 h and 4 h of METH exposure (Fig. 3.7A and 3.7B) show that 
there is no difference in ROS production induced by METH or LPS.  
On the contrary, after 24 h of METH exposure (Fig. 3.7C) there was a significant 
increase in ROS levels with 1 μM METH (157.34±14.22% of control, n=18) or 10 μM METH 
(167.70±18.09; *P<0.05; n=19) when compared to the control (control: 100.00±8.74, 
n=6). However, 100 μM METH and 1 μg/ml LPS did not induce a significant change in ROS 
production (69.39±3.36, n=19 and 88.82±8.43, n=20; respectively).  
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Figure 3.7 - METH effect on ROS levels in N9 cell line after (A) 1 h, (B) 4 h and (C) 24 h of exposure. The 
results are expressed as mean percentage of control ± SEM, n=4-20. *P<0.05, ***P<0.001 - Dunnet´s post-
test; significantly different from the control.  
 
It is known that METH may lead to ROS production in several brain regions, which 
can explain BBB disruption induced by this drug (Dietrich, 2009). Some studies have 
shown that METH promotes BBB disruption by induction of oxidative stress in endothelial 
cells (Ramirez et al., 2009). Also, results from Park and colleagues (Park et al., 2011) 
report an increase in NOX complex activity with a consequent production of ROS.  
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Based on these results, in the present study we also evaluated if METH could 
trigger ROS production by bEnd.3 cells. Once again, the fluorescent probe H2DCFDA was 
used, and endothelial cells were exposed to 250 μM, 1 mM and 3 mM METH during 
different time points (1, 4 and 24 h). Here, we did not observed any alterations regarding 
ROS levels (Fig. 3.8). 
 
Figure 3.8 - METH effect on ROS levels in endothelial cell line bend.3 after (A) 1 h, (B) 4 h and (C) 24 h. The 
results are expressed as mean percentage of control ± SEM; n= 3-9. A 
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METH is a highly addictive drug of abuse and a potent central nervous system 
stimulant (Krasnova and Cadet, 2009). It induces damage to different cells and systems, 
such as dopaminergic, serotonergic and glutamatergic neurotransmission (Krasnova, 
2009). Indeed, METH has several neurotoxic features that may include oxidative stress, 
excitotoxicity, mitochondrial dysfunction and neuroinflammation (Yamamoto and 
Raudensky, 2008; Krasnova and Cadet, 2009; Yamamoto et al., 2010). When  the 
homeostasis  of  the  brain  is  disturbed,  there  is  an  inflammatory  response  involving 
several  cells  and  molecules  that  can  culminate  in  cell  death.  In fact, 
neuroinflammation is one of the most prominent response to CNS injury, and usually 
involves  a  complex  response  of  all  cells  present in  the  CNS,  including neurons,  
astrocytes and  microglia. Moreover, microglial activation has already been described in 
the brain of METH users (Sekine et al., 2008), in mouse striatum (Lavoie et al., 2004) and 
hippocampus (Gonçalves et al., 2010). These cells when activated will release a diversity 
of inflammatory mediators, such as chemokines, cytokines, NO and MMPs (Czeh et al., 
2011).  
In the present study, we aimed to better clarify the inflammatory response 
triggered by METH in both microglial and endothelial cells. For that, we started by 
evaluating the release of nitrites, as an indirect measurement of nitric oxide, and LPS was 
used as a positive control to induce nitrite release. In fact, several studies reported that 
LPS induces nitrite release in microglial cells (Ferreira et al., 2010; Huo et al., 2011; Kacimi 
et al., 2011; Lijia et al., 2013;). Specifically, Lijia and colleagues observed a significant 
release of nitrite induced by 1 μg/ml LPS at different time points (1, 3, 6 and 12 h post-
exposure; Lijia et al., 2012). Moreover, using the same concentration of LPS, Kacimi and 
colleagues (2011) observed a significant increase in nitrite release 24 h after exposure. 
These results are in agreement with ours, since we observed an increase in nitrite levels 
at 1 h and 24 h post exposure. Although not statistically significant, at 4 h after LPS 
exposure there was a tendency to increase.  
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Regarding METH effects, an animal study has previously shown that METH 
increases nitrite levels in mice striatum at 72 h post drug administration (3x 5 mg/Kg) 
(Anderson and Itzhak, 2006). Here, using an in vitro approach, we also observed a 
significant increase of nitrite levels triggered by METH. In fact, we performed a time 
course study and concluded that METH was able to increase nitrite release by microglial 
cells 1 h after METH exposure. Tocharus and colleagues observed an increase in RNS but 
only at 6 h after METH (1.6 mM) exposure in HAPI cell line (Tocharus et al., 2010). These 
differences can be explained by the different cells used, time of drug exposure or/and 
different drug concentrations. Importantly, in our study all the concentrations used did 
not induced cell death. However, 1.6 Mm, METH significantly decreased HAPI cells 
viability 24 h and 48 h post-exposure (Tocharus et al., 2010). Thus, a cytotoxic response 
may be involved in a later NO release, whereas non-toxic concentrations induce a quick 
and transient response in microglial cells. Also, we only observed this effect using the 
lowest concentration of the drug suggesting that cell responses are somehow dependent 
on METH concentration. Accordingly, we have previously shown that a low concentration 
of METH increased endothelial cell permeability, whereas a higher concentration had no 
effect (Martins et al., 2013). Moreover, diverse studies also demonstrated that increase in 
nitrite levels in microglial cells are related with increased iNOS protein levels in LPS 
activated cells (Kim et al. 2008; Lijia et al., 2012). So, we can also hypothesize that METH 
could interfere with iNOS activity or/and levels leading to the observed increased levels of 
nitrites. Further studies are needed to clarify this hypothesis. Nevertheless, using a non-
specific NOS inhibitor, L-NAME, it was possible to completely prevent the effect induced 
by METH, which further prove the involvement of NO in microglial response to METH 
stimuli. In fact, L-NAME has already been described to diminish nitrite release in 
microglial cells stimulated with LPS (Kacimi et al., 2011; Lijia et al., 2012), and to prevent 
oxidative damage to oligodendrocyte progenitor cells (OPC; Pang et al., 2010).  
To further evaluate the involvement of nitrergic system in microglial response 
mediated by METH, 3-NT levels were evaluated at the critical time point 1 h after 1 μM 
METH administration. NO can react with O2
-. to produce peroxynitrite (ONOO-), a highly 
reactive oxidant specie. Our results clearly show an increase in 3-NT staining in N9 cell 
line, in agreement with increased nitrite release measured with the Griess assay.  
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Alterations in 3-NT levels have already been reported in the mice striatum 4 h 
after acute METH administration (30 mg/Kg, i.p.; Wang and Angulo, 2011). Furthermore, 
nNOS knockout mice showed no formation of 3-NT and DA degeneration in striatum after 
METH administration (Imam et al., 2001). Accordingly, once again we showed that L-
NAME was able to inhibit 3-NT immunoreactivity induced by METH in microglial cells. 
Moreover, other insults besides METH have demonstrated alterations on nitrergic system 
of glial cells. Ryu and McLarnon showed increased hippocampal 3-NT staining in the 
proximity of cerebral blood vessels corresponding to microglia/macrophages and 
astrocytes, 7 days after Aβ1–42 injection (Ryu and McLarnon, 2006). Also, Luth and 
colleagues detected nitrotyrosine in neurons, astrocytes and blood vessels in human AD 
patients. Interestingly, aberrant expression of nNOS in cortical pyramidal cells was highly 
co-localized with nitrotyrosine. Furthermore, iNOS and eNOS were highly expressed in 
astrocytes and co-localized with nitrotyrosine (Luth et al., 2002). In the present study we 
did not address iNOS localization, but would be interesting to explore this issue. 
After identifying a clear nitrosative stress response by microglial cells, we further 
aimed to identify the mechanisms involved in this effect. For that, we used a JAK/STAT 
pathway inhibitor (AG 490) that completely decreased nitrite release. The same was 
observed in BV2 cells triggered by LPS (Kacimi et al., 2011). Nevertheless, besides 
JAK/STAT, other intracellular pathways can be involved in NO release mediated by METH, 
such as NF-B and JNK that were shown to be activated by LPS in microglial cells (Kamici 
et al., 2011). Additionally, as abovementioned, it is important to clarify that, in the 
present study, all METH concentrations used in microglial cells did not affect cell viability. 
Nevertheless, the study performed by Kacimi and colleagues suggested that NO 
generation was accompanied by decreased viability (Kacimi et al., 2011). However, 
investigators observed that METH diminished microglial cells viability only with 
concentrations similar or superior to 800 μM, in a 24 h treatment, and similar or superior 
to 400 μM after 48 h exposure (Tocharus et al., 2010).  
 Besides microglia, endothelial cells have been recently shown to be highly affected 
by METH, and we currently know that BBB dysfunction can also be responsible for the 
neurotoxicity induced by METH. In fact, some studies have revealed that METH induces 
alterations in BBB function, which involved hyperthermia (Bowyer and Ali, 2006; Sharma 
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and Kiyatkin, 2009), oxidative stress (Ramirez et al., 2009; Park et al., 2011) and MMPs 
(Martins et al., 2011). Additionally, NO has already been implicated in METH-induced 
increased BBB permeability. Therefore, as abovementioned for microglial cells, we also 
analyzed nitrite release by endothelial cells. The results revealed no differences when 
compared with the control in cells treated with LPS, at all time points analyzed. 
Accordingly, Kamici and collaborators (2011) treated bEnd.3 cells with 1 μg/ml LPS for 24 
h and no differences were observed. However, METH (250 μM) were able to increase 
nitrites release but only at 1 h after drug exposure, similarly to what happened with 
microglia.  Once again, L-NAME completely blocked this effect. Martins and colleagues 
(2013), using rat BMVEC, observed that METH led to barrier breakdown at 1 μM as 
indicated by increased EC permeability and levels of eNOS phosphorylation plateaued 
after 1 h. Moreover, all these effects were blocked by L-NAME reinforcing NO 
involvement in BBB disruption. These results, associated with the ones obtained in the 
present study demonstrate that NO is a key player in METH-induced toxicity.  
It is well documented that METH can lead to neuronal cell death in several brain 
regions, such as striatum, cortex and hippocampus (Deng et al., 2001, 2002), or even to 
microglial toxicity (Coelho-Santos et al., 2011). However, the effect of METH in BBB, and 
more precisely on ECs, has been overlooked. Our present results show that METH has a 
direct time- and concentration-dependent effect on ECs viability. At a concentration of 1 
mM, METH decreased cell viability only after 4 h and 24 h, without an effect at 1 h. 
However, 3 mM METH was able to impair endothelial cell viability just after 1 h, which 
was even more significant after 4 h and 24 h. This can be an explanation to the observed 
decrease in nitrite release, since decreased cell viability certainly affects NO release by 
endothelial cells. In fact, the MTT assay is used to evaluate the metabolic state of the 
cells, and is known that METH alters mitochondrial function. This drug is a small lipophilic 
molecule, and so it can easily diffuse into the mitochondria, leading to the dissipation of 
the electrochemical gradient established by the ETC (Davidson et al., 2001), and inhibition 
of ATP synthesis, causing energy deficiency and subsequent mitochondrial dysfunction 
(Krasnova and Cadet, 2009). Another report also demonstrated that METH induced 
cytotoxicity in HBMVEC at a concentration of 2.5 mM, after 24 h treatment (Zhang et al., 
2009). 
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Another feature of METH-induced toxicity is the production of ROS. Thus, we 
further evaluate ROS production by microglial and endothelial cells in response to METH. 
Regarding microglial cells, our results show a significant increase in ROS production, when 
compared to the control, only 24 h after METH treatment. Little information is available 
concerning METH-induced ROS production in microglial cells. Tocharus and collaborators 
(2010) reported increased levels of ROS in HAPI cell line induced by METH, although they 
only evaluate the time point of 6 h and used a higher concentration of the drug (1.6 mM 
METH). Additionally, these authors used the same probe as we did (H2DCFDA), although 
the concentration was 3 times higher (we used 5 μM and they used 15 μM), which could 
affect the sensitivity of the probe. Moreover, there is some inconsistency concerning the 
production of ROS induced by LPS. Huo and collaborators (2011) tested diverse time 
points (1, 4, 6, 12 and 24 h) and observed a significant release of ROS only at 6 h in BV2 
cell line. However, in our study, no alterations were observed. These differences can be 
explained by the fact that different probes were used, since Huo and colleagues used the 
2',7'-dichlorodihydrofluorescein diacetate (CM-H2DCFDA )probe at 10 μM. 
Finally, concerning ROS production by endothelial cells, we did not detect any 
changes when compared with the control. In contrast, METH (2.5 mM) was able to 
significantly increase ROS production in HBMVEC. Another report also demonstrated 
dose-dependent increase in ROS production by HBMEC exposed during 24 h to METH 
concentrations going from 10 to 50 μM (Ramirez et al., 2009). The differences between 
the present work and the work of the mentioned authors may rely on the different BBB 
models used or also in the probes used.  
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Chapter 5 
Conclusions 
 
With the present work we concluded that METH triggers a nitrosative response on 
both microglial and endothelial cells, and an oxidative response on microglial cells. 
Moreover, the release of nitrites was prevented by the blockade of nitric oxide synthases. 
Importantly, these responses were induced by non-toxic concentrations of METH. 
Nevertheless, these effects seem to be dependent on drug concentration and time-
exposure. Additionally, we also identified the involvement of JAK/STAT pathway in nitrites 
release. In conclusion, the present work contributes to clarify how METH affects 
microglial and endothelial cells.  
 
 
 
 
Figure 4.1 - Squematic representation of the main conclusions concerning the initial objectives.  
 
 
METH  
Inflammatory process 
Microglia response 
Endothelial 
cells response 
↑RNS ↑RNS; ↑ROS 
Low concentrations 
High concentrations 
Cell death 
  
 
 
 
 
 
 
 
 
 
 Chapter 6 - References 
 
Chapter 6 - References 
 
71 
Chapter 6 
References 
 
Abbott N. J., Patabendige A. A. K., Dolman D. E. M., Yusof S. R., Begley D. J. (2010) Structure and function of 
the blood-brain barrier. Neurobiol Dis 37: 13-25. 
Abbott, N., Ronnback, L. & Hansson (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat 
Rev Neurosci, 7, 41-53.  
Akira, S., Takeda, K., and Kaisho,T. (2001) Toll-like receptors: critical  proteins  linking innate  and  acquired  
immunity.  Nat Immunol, 2: 675-680. Review. 
Albertson T. E., Derlet, R.W. and Van Hoozen, B. E. (1999) Methamphetamine  and the expanding 
complications of amphetamines. West J Med, 170: 214-219. Review. 
Alderton, W. K., Cooper, C.E. and Knowles, R.G. (2001) Nitric oxide synthases: structure, function and 
inhibition. Biochem J 357(Pt 3): 593-615. 
Ali, S. F., Newport, G. D., Holson, R. R., Slikker, W. Jr. and Bowyer, J. F. (1994) Low environmental 
temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine 
neurotoxicity in mice. Brain Res., 658: 33-38. 
Anderson, K.L. and Izhak, Y. (2006) Methamphetamine-induced selective dopaminergic neurotoxicity is 
accompanied by an increase in striatal nitrate in the mouse. Ann N Y Acad Sci, 1074: 225-233. 
Anglin, M. D., Burke, C., Perrochet, B., Stamper, E. and Dawud-Noursi, S. (2000). History of the 
methamphetamine problem.  J Psychoactive Drugs, 32(2):137-41. 
Babior, B.M. (199) NADPH oxidase: an update. Blood, 93: 1464-1476. 
Barr, A. M., Panenka, W. J., MacEwan, G. W., Thornton, A. E., Lang, D. J., Honer, W. G. and Lecomte,  T.  
(2006) The need for speed: an update on methamphetamine addiction.  J Psychiatry Neurosci 31(5): 301-
313. Review. 
Beckman, J.S., Ye, Y.Z., Anderson, P.G., Chen, J., Accavitti, M.A., Tarpey, M.M., White, C.R. (1994) Extensive 
nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem 
Hoppe-Seyler, 375:81–88. 
Begley, D.; Brightman, M.W. (2003) Strutural and functional aspects of the blood brain barrier. Progr Drug 
Res. 61:39-78.  
Bento, A.R., Baptista, S., Malva, J.O., Silva, A.P. and Agasse, F. (2011). Methamphetamine exerts toxic 
effects on subventricular zone stem/progenitor cells  and  inhibits  neuronal differentiation.  Rejuvenation 
Res, 14(2):205-14. 
Chapter 6 - References 
 
72 
Berman, S., O'Neill, J., Fears, S., Bartzokis, G., and London, E.D. (2008). Abuse of amphetamines and 
structural abnormalities in the brain. Ann N Y Acad Sci, 1141:195-220. Review.  
Block, M.L., Zecca, L. and Hong, J.S. (2007) Microglia-mediated neurotoxicity: uncovering the molecular 
mechanisms. Nat Rev Neurosci, 8: 57-69. 
Boer, A.G., and Gaillard, P.J. (2006) Blood-brain barrier dysfunction and recovery. J Neural Transm, 113: 
455-462. 
Bowyer, J.F. (1995) The role of hyperthermia in amphetamine´s interactions with NMDA receptors nitric 
oxide, and age to produce neurotoxicity. Ann N Y Acad Sci, 765, 309-310. 
Bowyer, J.F. and S. Ali (2006) High  doses  of  methamphetamine  that  cause  disruption  of  the  blood-brain  
barrier  in  limbic  regions  produce  extensive  neuronal  degeneration  in  mouse  hippocampus, Synapse 
60: 521-32.  
Bredt, D. S., Glatt, C.E., Hwang, P.M., Fotuhi, M., Dawson, T.M. and S. H. Snyder (1991) Nitric oxide synthase 
protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with 
NADPH diaphorase, Neuron 7(4): 615-24. 
Bredt, D. S., Hwang, P.M. and Snyder, S.H. (1990) Localization of nitric oxide synthase indicating a neural 
role for nitric oxide Nature 347(6295): 768-70. 
Bredt, D.S. and Snyder, S.H. (1994) Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem, 63: 
175-95. 
Brown, J.M., Quinton, M.S., Yamamoto, B.K. (2005) Methamphetamine-induced inhibition of mitochondrial  
complex  II:  roles of glutamate and peroxynitrite.  J Neurochem, 95: 429-436. 
Burguillos, M.A., Deierborg, T., Kavanagh, E., Persson, A., Hajji, N., Garcia-Quintanilla, A., Cano, J., Brundin, 
P., Englund, E., Venero, JL. and Joseph, B. (2011) Caspase  signalling controls  microglia  activation  and 
neurotoxicity. Nature. 472(7343):319-24. 
Burrows, K.B., Gudelsky, G. and Yamamoto, B.K. (2000) Rapid and transient inhibition of mitochondrial 
function following methamphetamine or 3,4-methylenedioxymethamphetamine administration. Eur J 
Pharmacol, 398: 11-18. 
Busse, R. and Mulsch, A. (1990) Induction of nitric oxide synthase by cytokines in vascular smooth muscle 
cells. FEBS Lett 275(1-2): 87-90. 
Cadet, J.L., Ordonez, S.V. and Ordonez, J.V. (1997) Methamphetamine induces apoptosis in immortalized 
neural cells: protection by the proto-oncogene, bcl-2. Synapse, 25(2):176-84. 
Cadet, J.L. (2002) Contemporary Clinical Neuroscience: Roles of gluatamate, nitric oxide, oxidative stress 
and apoptosis in the neurotoxicity of methamphetamine in Herman, B.H. (Ed.), Glutamate and addition 
Humana Press Inc, Totowa, NJ. pp 201-210. 
Chapter 6 - References 
 
73 
Cadet, J.L., Ali, S.F., Rothman, R.B. and Epstein, C.J. (1995) Neurotoxicity, drugs and abuse, and the CuZn-
superoxide dismutase transgenic mice. Mol Neurobiol, 11(1-3): 155-163. 
Cardoso, F.L., D. Brites and Brito, M.A. (2010) Looking at the blood-brain barrier: Molecular anatomy and 
possible investigation approaches.  Brain Res Rev, 64(2): 328-363. 
Carson, M.; Thrash, J.; Walter, B. (2006) The cellular response in neuroinflammation: The role of leukocytes, 
microglia and astrocytes in neuronal death and survival. Clin Neurosci Res, 6: 237–245. 
Cass, W. A. and Manning, M. W. (1999) Recovery  of  presynaptic  dopaminergic functioning  in  rats  treated  
with  neurotoxic doses  of  methamphetamine.  J Neurosci, 19: 7653-7766. 
Cecchelli, R., Berezowski, V., Lundquist, S., Culot, M., Rentfel, M., Dehouck, M.P. and Fenart, L. (2007) 
Modelling of the blood-brain barrier in drug discovery and development. Nat Rev Drug Discov 6(8): 650-661. 
Coelho-Santos V., Gonçalves J., Fontes-Ribeiro C., Silva A.P. (2012) Prevention  of methamphetamine-
induced  microglial  cell  death  by  TNF-α  and  IL-6  through activation of the JAK-STAT pathway. J 
Neuroinflamm, 9:1-14.  
Couraud, P.O. (1994) Interactions between lymphocytes, macrophages, and central nervous system cells.  J 
Leukoc Biol, 3: 407-15. Review. 
Culotta E., D.E. Koshland Jr. (1992.) NO news is good news. Science, 258: 1862-1865. 
Cunha-Oliveira, T., Rego, A.C., Cardoso, S.M., Borges, F., Swerdlow, R. H., Macedo, T. and Oliveira, C. R. 
(2006). Mitochondrial dysfunction  and  caspase  activation  in  rat cortical  neurons  treated  with  cocaine  
or amphetamine. Brain Res, 1089(1): 44-54. 
Czeh, M., Gressens, P. and Kaindl, A.,M. (2011) The ying and yang of microglia. Dev Neurosci, 33: 199-209. 
Darke, S., Kaye, S., McKetin, R. and Duflou, J. (2008) Major physical and psychological harms of 
methamphetamine use. Drug Alcohol Rev., 27: 253-262. Review. 
Deng, X., Wang, Y., Chou, J., Cadet, J.L. (2001) Methamphetamine  causes  widespread apoptosis  in  the  
mouse  brain:  evidence  from using  an  improved  TUNEL  histochemical method. Brain Res, Mol, Brain Res, 
93(1):64-9. 
Deng  X., Cai N.S., McCoy M.T., Chen W., Trush M.A., Cadet  J.L.,  (2002) Methamphetamine  induces  
apoptosis  in  an immortalized  rat  striatal  cell  line  by  activating the  mitochondrial  cell  death  pathway. 
Neuropharmacology, 42:837–845. 
Derlet, R.W. and Heischober, B. (1990) Methamphetamine-Stimulant of the 1990s?West J. Med., 153: 625-
628. Review. 
Dietrich, J.B. (2009) Alteration of brain barrier function by methamphetamine and cocaine. Cell Tissue Res, 
336: 385-392. 
Chapter 6 - References 
 
74 
Dijkstra, G., Moshage, H., van Dullemen, H.M., de Jager-Krikken, A., Tiebosch, A.T., Kleibeuker, J.H., Jansen, 
P.L., van Goor, H. (1998) Expression of nitric oxide synthases and formation of nitrotyrosine and reactive 
oxygen species in inflammatory bowel disease. J Pathol, 186:416–421. 
Dikalov, S. (2011) Cross talk between mitochondria and NADPH oxidases. Free Radic Biol Med, 51:1289-
1301. Review. 
Dilger, R.N. and Johnson, R.W. (2008) Aging,  microglial  cell  priming,  and  the discordant  central  
inflammatory  response  to signals  from  the  peripheral  immune  system.  J Leukoc Biol, 84(4):932-9. 
Donaldson, M. and Goodchild, J. H. (2006) Oral health of the methamphetamine abuser. Am J Health-Syst 
Pharm, 63(21): 2078-2082. 
Dziennis S., Alkayed N.J. (2008) Role of signal transducer  and  activator  of  transcription  3  in neuronal  
survival  and  regeneration.  Rev Neurosci, 19(4-5): 341-61. Review. 
Farooqui, A.A., Horrocks, L.A. and Farroqui, T. (2007) Modulation of inflammation in brain: a matter of fat. J 
Neurochem, 101: 577-599. 
Ferreira, R., Xapelli, S., Santos, T., Silva, A.P., Cristóvão, A., Cortes, L. and Malva, J.O. (2010) Neuropeptide Y 
modulation of interleukin-1{beta} (IL-1{beta})-induced nitric oxide  production  in  microglia. J Biol Chem, 
285(53): 41921-34. 
Fleckenstein, A. E., Volz, T. J., Riddle, E. L., Gibb, J. W. and  Hanson,  G. R. (2007) New insights into the 
mechanism of action of amphetamines.   Ann Rev Pharmacol Toxicol, 47: 681-698. Review. 
Frei, K., Lins, H., Schwerdel, C. and Fontana, A. (1994) Antigen presentation in the central nervous system. 
The inhibitory effect of IL-10 on MHC class II expression and production of cytokines depends on the 
inducing signals and the type of cell analyzed.  J Immunol, 152(6): 2720-2728. 
Friedman, S. D., Castañeda, E. and Hodge, G.K.  (1998)  Long-term  monoamine  depletion, differential  
recovery,  and  subtle  behavioral impairment  following  methamphetamine-induced  neurotoxicity.  
Pharmacol  Biochem Behav, 61: 35-44. 
Garthwaite, J., Charles, S.L. and Chess-Williams, R. (1988) Endothelium-derived relaxing factor release on 
activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature, 336(6197): 385-
388. 
Garthwaite, J., Garthwaite, G., Palmer, R.M. and Moncada, S. (1989) NMDA receptor activation induces 
nitric oxide synthesis from arginine in rat brain slices. Eur J Pharmacol, 172(4-5): 413-416. 
Gluck, M.R., Moy, L. Y., Jayatilleke, E., Hogan, K.A., Manzino, L. and Sonsalla, P. K. (2001) Parellelel increses 
in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment. J 
Neurochem, 79: 152-160. 
Chapter 6 - References 
 
75 
 Gonçalves, J., Martins, T., Ferreira, R., Milhazes, N., Borges, F., Ribeiro, C., Malva, J., Macedo, T., Silva, A. 
(2008) Methamphetamine-induced early increase of IL-6 and TNF-alpha mRNA expression in the mouse 
brain. Ann N Y Sci 1139: 103-111. 
Gonçalves, J.; Baptista, S.; Martins, T.; Milhazes, N.; Borges, F.; Ribeiro, C.; Malva, J.; Silva, A. (2010) 
Methamphetamine-induced neuroinflammation and neuronal dysfunction in the mice hippocampus: 
preventive effect of indomethacin. Eur J  Neurosci 31: 315-326. 
Gordon, S. (2002) Pattern recognition receptors: doubling up for the innate response. Cell, 111: 927-930. 
Gorina, R., Sanfeliu, C., Galitó, A., Messeguer, À. And Planas, A.M. (2007) Exposure of glia to pro-oxidant 
agents revealed selective Stat1 activation by H2O2 and Jak2-independent antioxidant features of the Jak2 
inhibitor AG490. Glia, 55(13): 1313-1324.  
Hanisch, U.K. Kettenmann, H. (2007) Microglia: active sensor and versatile effector cells in the normal and 
pathologic brain. Nat Neurosc, 10: 1387-1394. 
Harvey, D.C., Lacan, G., Tanious, S. P. and Melega, W. P.(2000) Recovery  from methamphetamine  induced  
long-term nigrostriatal  dopaminergic  deficits  without substantia nigra cell loss. Brain Res, 871: 259-270. 
Hauwel, M., Furon, E., Canova, C., Griffiths, M., Neal, J. and Gasque, P. (2005) Innate (inherent) control of 
brain infection, brain inflammation and brain repair: the role of microglia, astrocytes, “protective” glial stem 
cells and stromal ependymal cells. Brain Res Rev, 48: 220-233. 
Hawkins, B.T. and Davis, T.P. (2005) The Blood-Brain Barrier/Neurovascular Unit in Health and Disease. 
Pharmacol Rev, 57(2): 173-85. 
Heim, M.H. (1999) The JAK-STAT pathway: cytokine signalling from the receptor to the nucleus. J Signal 
Transduct Res, 19(1-4): 75-125. 
Hevel, J. M., White, K.A. and Marletta, M.A. (1991) Purification of the inducible murine macrophage nitric 
oxide synthase. Identification as a flavoprotein. J Biol Chem, 266(34):22789-91. 
Hisanaga, K., Asagi, M., Itoyama, Y. and Iwasaki, Y. (2001) Increase in peripheral CD4 bright+CD8 dull+ Tcells 
in Parkinson disease. Arch Neurol, 58: 1580-1583. 
Hogan, K. A., Staal, R. G., Sonsalla, P. K.(2000)  Analysis  of  VMAT2  binding  after methamphetamine  or  
MPTP  treatment: disparity  between  homogenates  and  vesicle preparations. J Neurochem, 74: 2217-
2220. 
Homer, B. D., Solomon, T. M., Moeller, R. W., Mascia, A., DeRaleau, L. and Halkitis, P.N.  (2008). 
Methamphetamine abuse and impairment of social functioning: a review of the underlying 
neurophysiological causes and behavioral implications. Psychol Bull, 134: 301–310. Review. 
Huang, C., Ma, R., Sun, S., Wei, G., Fang, Y., Liu, R. and Li, G. (2008) JAK2/STAT3 signaling pathway mediates 
thrombin-induced proinflammatory actions of microglia in vitro. Journal of Neuroimmunology 204: 118-125.  
Chapter 6 - References 
 
76 
Huber, J.  D., Egleton, R.  D. and Davis,T. P. (2001) Molecular physiology and pathophysiology  of  tight  
junctions  in  the blood-brain  barrier. Trends Neurosci, 24(12): 719-725. Review. 
Huo, Y., Rangarajan, P., Ling, E. and Dheen, S.T. (2011) Dexamethasone inhibits the Nox dependent ROS 
production via suppression of MKP-1-dependent MAPK pathways in activated microglia. BMC Neuroscience, 
12: 49. 
Imam, S.Z., Itzhak, Y., Cadet, J.L., Islam, F., Slikker, W. Jr. and Ali, S.F. (2001). Methamphetamine-induced 
alteration in striatal  p53 and bcl-2 expressions in mice. Brain Res Mol Brain Res., 91(1-2):174-8. 
Iwashita, A., Mihara, K., Yamazaki, S., Hattori, K., Matsuoka, N., Mutoh, S. (2004) A new poly(ADP-ribose)  
polymerase  inhibitor, FR261529  [2-(4-chlorophenyl)-5-quinoxalinecarboxamide],  ameliorates 
methamphetamine-induced  dopaminergic neurotoxicity  in  mice. J Pharmacol Exp Ther, 310(3):1114-24. 
Instituto da Droga e da Toxicodependência (IDT), I.P. (2011), Relatório anual 2011. A situação do país em 
matéria de drogas e toxicodependências, IDT, Lisboa. 
Itzhak, A., Ali, S.F. (2006) Role of nitrergic system in behavioral and neurotoxic effects of amphetamine 
analogs. Pharmacol Exp Ther, 109, 246-262. 
Ischiropoulos, H., Gow, A., Thom, S.R., Koo,y N.W., Royall, J.A., Crow, J.P (1999) Detection of reactive 
nitrogen species using 2,7-dichlorodihydrofluorescein and dihydrorhodamine 123. Methods Enzymol, 
301:367–373.  
LaVoie, M.J., Card, J.P. and Hastings, T.G. (2004) Microglial activation  precedes dopamine  terminal  
pathology  in methamphetamine-induced  neurotoxicity, Exp Neurol, 187: 47-57. 
Matsuura, S., Ishida, J., Yamamoto, H., Iztak, Y. and Ali, S. K. (2006) Role of nitrergic system in behavioral 
and neurotoxic effects of methamphetamines analogs. Pharmacol Ther, 109, 246-262. 
Jayanthi, S., Deng, X., Bordelon, M., McCoy, M.T. and Cadet J.L. (2001) Methamphetamine causes 
differential regulation of pro-death and anti-death Bcl-2 genes in the mouse neocortex. FASEB J, 
15(10):1745-52. 
Jayanthi, S., Deng, X., Noailles, P.A., Ladenheim, B. and Cadet, J. L. (2004) Methamphetamine  induces  
neuronal  apoptosis via cross-talks between endoplasmic reticulum and  mitochondria-dependent  death  
cascades. FASEB J, 18: 238-251. 
Jiménez, A., Jordà, E.G., Verdaguer, E., Pubill, D., Sureda, F.X., Canudas, A.M., Escubedo, E., Camarasa, J., 
Camins, A. and Pallàs, M. (2004) Neurotoxicity  of  amphetamine derivatives  is  mediated  by  caspase  
pathway activation  in  rat  cerebellar  granule  cells. Toxicol Appl Pharmacol, 196(2):223-34. 
Kacimi, R., Giffard, R.G. and Yerani, M.A. (2011) Endotoxin-activated microglia injure brain derived 
endothelial cells via NF-κB, JAK/STAT and JNK stress kinase pathways. Journal of Inflammation, 8:7 
Chapter 6 - References 
 
77 
Kim, H.S., Cho, I.H., Kim, J.E., Shin, Y.J., Jeon, J.H., Kim, Y., Young, M.Y., Lee, K.H., Lee, J.W., Lee, W.J., Ye, S. 
and Chung, M. (2008) Ethyl pyruvate has an anti-inflammatory effect by inhibiting ROS-dependent STAT 
signaling in activated microglia. Free Radical Biology & Medicine 45:950-963. 
Kim, S.U. and de Vellis, J. (2005)  Microglia in  health  and  disease.  J Neurosci Res, 81: 302-313. 
Kim, O.S. Park, E.J.,Joe, E.H. and Jou, I. (2002) JAK-STAT signaling mediates gangliosides-induced 
inflammatory responses in brain microglial cells. J Biol Chem, 277(43): 40594-601. 
Kish, S.J. (2008) Pharmacological mechanism of crystal meth. CMAJ, 178:1679-1682.  
Kishimoto, T., Taga, T., Akira, S., (1994) Cytokine signal transduction. Cell 76: 253–262. 
Kiyatkin, E.A. and Sharma, H.S. (2009) Acute methamphetamine intoxication: brain hyperthermia, blood-
brain barrier, brain edema and morphological cell abnormalities. Int Rev Neurobil, 88: 65-100. 
Klongpanichapak, S., Govitrapong, P., Sharma, S.K. and Ebadi, M. (2006) Attenuation of cocaine and 
methamphetamine neurotoxicity by coenzyme Q10. Neurochem Res, 31: 303-311. 
Kocherginsky, N. (2000) Acidic lipids, Hþ-ATPases, and mechanism of oxidative phosphorylation. Physico-
chemical ideas 30 years after P. Mitchell’s Nobel Prize award. Prog Biophys Mole Bioly, 99:20-41. Review.  
Kraft, A.D., Harry, G.J. (2011) Features of microglia and neuroinflammation relevant to environmental 
exposure and neurotoxicity. Int J Environ Res Public Health, 8(7): 2980-3018. 
Krasnova, I., Cadet, J. (2009) Methamphetamine toxicity and messengers of death. Brain Res Rev 60(2): 379-
407. 
Lijia, Z., Siqi, Z., Xiaoxiao, W., Chunfu, W. and Jingyu, Y. (2012) A self-proliferating cycle mediated by reactive 
oxide species and nitric oxide exists in PLS-activated microglia. Neurochem int, 61: 1220-1230. 
Lucas, S.M., Rothwell, N.J. and Gibson, R.M. (2006) The role of inflammation in CNS injury and disease. Br J 
Pharmacol, 147 Suppl 1: S232-240. 
Lull, M.E., Block, M.L. (2010) Microglial activation and chronic degeneration. Neurotherapeutics 7(4): 354-
65. 
Luth, H., Munch, G. and Arendt, T. (2002) Aberrant expression of NOS isoforms in Alzheimer’s disease 
isstructurally related to nitrotyrosine formation. Brain Res, 953: 135-143. 
MacMicking, J., Xie, Q.W. and Nathan, C. (1997) Nitric oxide and macrophage function. Annu Rev Immunol, 
15: 323-350. 
Mahajan, S.D., Aalinkeel, R., Sykes,D.E., Reynolds, J.L, Bindukumar, B., Adal, A., Qi, M., Toh, Xu, J.G., Prasad, 
P.N. and  S.A. Schwartz, S.A. (2008) Methamphetamine  alters  blood  brain  barrier  permeability  via  the 
modulation of tight junction expression: Implication for HIV-1 neuropathogenesis in the context of drug 
abuse. Brain Res 1203: 133-48. 
Chapter 6 - References 
 
78 
Marshall J. F.  and O'Dell  S. J.,  (2012)  Methamphetamine  influences  on  brain  and  behavior: unsafe at 
any speed? Trends Neurosci. 35:536-45. 
Martins, T., Baptista, S., Gonçalves, J., Leal, E., Milhazes,  N., Borges, F., Ribeiro, C.F., Quintela, O.,  Lendoiro, 
E., López-Rivadulla, M., Ambrósio, A.F. and  Silva, A.P. (2011) Methamphetamine  transiently increases  the  
blood-brain  barrier  permeability  in  the  hippocampus:  role  of  tight  junction  proteins  and matrix 
metalloproteinase-9. Brain Res, 1411: 28-40.  
Martins T., Burgoyne T., Kenny B., Hudson N.,  Futter  C. E., Ambrósio A. F., Silva A. P., Greenwood J., 
Turowski P. (2013) Methamphetamine-induced nitric oxide promotes vesicular transport in blood-brain 
barrier endothelial cells. Neuropharmacology 65: 74-82. 
Meredith, C. W., Jaffe, C., Ang-Lee, K., and Saxon, A. J. (2005) Implications of Chronic Methamphetamine 
Use:  A Literature  Review. Harv Rev Psychiatry, 13(3): 141-154. 
Montesano, R., M. Pepper, U. Mohle-Steinlein, W. Risau, E. Wagner and L. Orci (1990) Increased proteolytic  
activity  is  responsible  for  the  aberrant  morphogenetic  behavior  of  endothelial  cells expressing the 
middle T oncogene. Cell, 62: 435-45. 
Mosmann, T. (1983) Rapid  colorimetric  assay  for  cellular growth  and  survival:  application  to  
proliferation  and  cyto-toxicity assays.  J  Immunol Methds, 65: 55-63. 
Muller, F. (2000) The nature and mechanism of superoxide production by the electron transport chain: Its 
relevance to aging. J Am Aging Assoc , 23(4): 227–253. 
Munneer, A., Alikunju, S., Szlachetka, A.M., Murrin, L.C. and Haorah, J. (2011) Impairment of brain 
endothelial glucose transporter by methamphetamine causes blood-brain barrier dysfunction. Mol 
Neurodegener, 6: 23. 
Nakamura, Y. (2002) Regulating  Factors  for Microglial Activation, Biol. Pharm Bull, 25:945-953.  
Nash, J. F. and Yamamoto, B. K. (1992) Methamphetamine neurotoxicity and striatal glutamate release: 
comparison to 3, 4-methylenedioxymethamphetamine.  Brain Res, 581: 237-243. 
Nguyen, M.D., Julien, J.P. and Rivest, S. (2002) Innate immunity: the missing link in neuroprotection and 
neurodegeneration? Nat Rev Neurosci, 3: 216-227. 
Palmer, R.M., D.S. Ashton and S. Moncada (1988) Vascular endothelial cells synthesize nitric oxide from L-
arginine, Nature 333(6174): 664-6. 
Pang, Y., Campbell, B., L., Fan, L., Cai, Z. and Rhodes, P. (2010) Lipopolysaccharide-activated microglia 
induce death of oligodendrocyte progenitor cells and impede their development. Neuroscience, 166(2): 
464-475. 
Park, J.I., Strock, C.J., Ball, D.W. and Nelkin, B.D. (2003)The Ras/Raf/MEK/extracellular  signal-regulated 
kinase  pathway  induces  autocrine-paracrine growth  inhibition  via  the  leukemia  inhibitory 
factor/JAK/STAT  pathway.  Mol Cell Biol, 23(2):543-54. 
Chapter 6 - References 
 
79 
Park, K.M. and Bowers, W.J. (2010) Tumor necrosis factor-alpha mediated signaling in neuronal 
homeostasis and dysfunction. Cell Signal, 22: 977-983. 
Perez, J. A. Jr., Arsura, E. L. and Strategos, S. (1999). Methamphetamine-related stroke: four cases. J Emerg 
Med,. 17(3):469-71. 
Persidsky, Y., S.H. Ramirez, J. Haorah  and  G.D.  Kanmogne  (2006) Blood-brain  barrier:  Structural 
components and function under physiologic and pathologic conditions. J Neuroimmune Pharmacol 1: 223-
36. 
Prast, H. and Philippu, A. (2001) Nitric oxide as modulator of neuronal function Prog Neurobiol 64(1): 51-68. 
Quinton, M.S. and Yamamoto, B.K. (2006) Causes and consequences of methamphetamine and MDMA 
toxicity (2006). AAPS J, 8, E337-347. 
Ramirez, S. H., Potula, R., Fan, S., Eidem, T., Papugani, A., Reichenbach, N., Dykstra, H., Weksler, B.B., 
Romero, I.A., Couraud, P.O. and Perdidsky, Y. (2009) Methamphetamine disrupts blood-brain barrier 
function by induction of oxidative stress in brain endothelial cells . J Cereb Blood Flo  Metab 29: 1933-45. 
Rawlings, J.S., Rosler, K.M., and Harrison, D.A. (2004) The JAK/STAT signalling pathway. J cell Sci, 117: 1281-
1283. 
Ribic, A., Zhang, M., Schlumbohm, C., Matz-Rensing, K., Uchaska-Ziegler, B., Flugge, G., Zhang, W., Walter, L. 
and Fuchs, E. (2010) Neuronal MHC class I molecules  are involved in excitatory synaptic transmission at the 
hippocampal mossy fiber synapses of marmoset monkeys. Cell Mol Neurobiol, 30: 827-839. 
Ricaurte, G. A., Guillery, R. W., Seiden, L.S., Schuster, C.R. and Moore, R.Y. (1982) Dopamine nerve terminal 
degeneration produced by high doses of methylamphetamine in the rat brain. Brain Res, 235(2): 93–103. 
Ricaurte, G., A. and McCann, U. D. (1992) Neurotoxic  amphetamine  analogues:  effects  in monkeys and 
implications for humans. Ann NY Acad Sci, 648: 371-338. Review. 
Righi, M., Mori, L., De Libero, G., Sironi, M., Biondi, A., Mantovani, A., Donini, SD. and Ricciardi-Castagnoli,  
P.  (1989) Monokine production  by  microglial  cell  clones.  Eur J Immunol 8:1443-1448. 
Rose, M., and Grant, J. (2008). Pharmacotherapy for methamphetamine dependence: A review  of the 
pathophysiology of methamphetamine addiction and the theoretical basis and efficacy of 
pharmacotherapeutic interventions. Ann Clin Psychiatry, 20(3): 145-155. 
Ryu, J.K., and McLarnon, J.G. (2006) Minocycline or iNOS inhibition block 3-nitrotyrosine increases and 
blood –brain barrier leakin ess in amyloid beta-peptide-injected rat hippocampus. Exp Neurol, 198: 552-557. 
Sandoval, K. and Witt, K. (2008) Blood-brain barrier tight junction permeability and ischemic stroke.  
Neurobiol  Dis 32: 200-219. 
Schmidt,H., Pollock,H.J.S., Nakane, M., Gorsky, L.D., Forstermann U. and Murad, F. (1991). Purification of a 
soluble isoform of guanylyl cyclase-activating-factor synthase. Proc Natl Acad Sci USA, 88(2): 365-9. 
Chapter 6 - References 
 
80 
Seiden, L.S., Commins, D.L., Vosmer, G., Axt, K. and Marek, G.  (1988).  Neurotoxicity in  dopamine  and  5-
hydroxytryptamine terminal  fields:  a  regional  analysis  in nigrostriatal  andmesolimbic  projections.  Ann N 
Y Acad Sci, 537: 161–172. Review. 
Sekine, Y., Ouchi, Y., Takei, N., Yoshikawa, E., Nakamura, K., Futatsubashi, M., Okada, H., Minabe, Y., Suzuki, 
K., Iwata, Y., Tsuchiya, K. J., Tsukada, H., Iyo, M. and Mori, N. (2006) Brain serotonin transporter density and 
aggression in abstinent methamphetamine abusers. Arch Gen Psychiatry, 63: 90-100. 
Gold, M. S. and Cadet, J.L. (2008) Methamphetamine causes microglial activation in the brains of human 
abusers. J Neurosci, 28: 5756-5761.  
Sharma, H., Kiyatkin, E. (2009). Rapidmorphological brain abnormalities during acute methamphetamine 
intoxication in the rat: an experimental study using light and electron microscopy. J Chem Neuroanat 37: 18-
32. 
Shuai, K., Liu, B. (2003) Regulation of JAK/STAT signaling in the immune system. NAT REV IMMUNOL 3: 900-
911. Review. 
Simões, P.F., Silva, A.P., Pereira, F.C., Marques, E., Milhazes, N., Borges, F., Ribeiro, C.F. and Macedo, T.R. 
(2007). Methamphetamine  induces  alterations  on hippocampal  NMDA  and  AMPA  receptor subunit  
levels  and  impairs  spatial  working memory. Neuroscience, 150(2):433-41. 
Smith, K.J., Butler, T.R. and Prendergast, M.A. (2010) Inhibition of sigm-1 receptor reduces N-methyl-D-
aspartate induced neuronal injury in methamphetamine-exposed and –naive hippocampi. Neurosci Lett, 
481: 144-148.  
Sonsalla, P.K., Riordan, D.E. and Heikkila, R.E. (1991) Competitive and noncompetitive antagonists at N-
methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice. J 
Pharmacol Exp Ther, 256: 506–512.   
Stone, D.K., Reynolds, A.D., Mosley, R.L. and Gendelman, H.E. (2009) Innate and adaptive immunity for the 
pathology of Parkinson´s disease. Antioxid Redox Signal, 11: 2151-2166. 
Stuehr, D.J., Cho, H.J., Kwon, N.S., Weise, M.F. and Nathan, C.F. (1991) Purification and characterization of 
the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein.  Proc 
Natl Acad Sci USA 88(17): 7773-7777. 
Sulzer, D. and Rayport, S. (1990) Amphetamine and  other  psychostimulants reduce pH gradients in 
midbrain dopaminergic neurons and chromaffin granules: a mechanism of action. Neuron, 5(6): 797-808. 
Sulzer, D., Sonders, M.S., Poulsen, N.W. and Galli, A. (2005) Mechanisms  of neurotransmitter  release  by  
amphetamines:  A review.  Prog Neurobiol, 75:  406–433. 
Thomas, D.; Dowgiert, J.; Geddes, T.; Fracescutti-Verbeem, D.; Liu, X.; Kuhn, D.; (2004). Microglial activation 
is a pharmacologically specific marker for the neurotoxic amphetamines. Neurosci Lett 367: 349-354. 
Chapter 6 - References 
 
81 
Thomas, D.; Francescutti-Verbeem, D. and Kuhn, D. (2008) The newly synthesized pool of dopamine 
determines the severity of methamphetamine-induced neurotoxicity. J. Neurochem,. 105:605-616. 
Thomas, D.; Kuhn, D. (2005). Cyclooxygenase-2 is an obligatory factor in methamphetamine-induced 
neurotoxicity. J Pharmacol Exp Ther, 313: 870-876. 
Thompson, P. M., Hayashi, K. M., Simon, S. L.,  Geaga,  J.  A., Hong, M.  S., Sui, Y., Lee, J. Y.,  Toga,  A.W., Ling, 
W. and London, E. D. (2004) Structural  abnormalities  in  the  brains of human subjects who use 
methamphetamine. Neurosci, 24 (26): 6028-6036. 
Tian, C., Murrin, L.C. and Zheng, J.C. (2009) Mitochondrial fragmentation is involved in methamphetamine-
induced cell death in rat hippocampal neural progenitor cells. PLoS One, 4(5): e5546. 
Tiskas, D. (2007) Analysis of nitrite and nitrate in biological fluids by assays based on the Griess reaction: 
appraisal of the Griess reaction in the L-arginine/nitric oxide area of research. J Chromatogr B Analyt 
Technol Biomed Life Sci, 851: (1-2): 51-70. 
Tocharus, J., Khonthun, C., Chongthammakun, S., Govitrapong, P. (2010) Melatonin attenuates 
methamphetamine-induced overexpression  of  pro-inflammatory  cytokines in  microglial  cell  lines.  J 
Pineal Res, 48(4):347-52.   
United  Nations  Office  on  Drugs  and  Crime  (UNODC)  (2012)  World  Drug  Report.  UNODC, Vienna.  
Urrutia A., Rubio-Araiz A., Gutierrez-Lopez M. D., ElAli A., Hermann D.M., O'Shea E., Colado M. I., 2013.  A  
study  on  the  effect  of  JNK  inhibitor,  SP600125,  on  the  disruption  of blood–brain barrier induced by 
methamphetamine. Neurobiol Di,s 50:49-58. 
Volkow, N. D., Chang, L., Wang, G. J., Fowler, J. S., Franceschi, D.,  Sedler,  M., Gatley,  S.  J.,  Miller,  E.,  
Hitzemann,  R.,  Ding, Y. S. and Logan, L. (2001) Loss of dopamine transporters  in  methamphetamine  
abusers recovers  with  protracted  abstinence.  J Neurosci, 21(23): 9414-9418. 
Wagner, G.C., Ricaurte, G.A., Seiden, L.S., Schuster, C.R., Miller, R.J. and Westley J. (1980) Long-lasting  
depletions  of  striatal dopamine  and  loss  of  dopamine  uptake  sites following  repeated  administration  
of methamphetamine. Brain Res, 181(1):151-60. 
Walter, L. and Neuman, H. (2009) Role of microglia in neuronal degeneration and regeneration. Semin 
Immunopathol, 31: 513-525. 
Wang, C., Shuaib, A. (2007) Critical role of microvasculature basal lamina in ischemic brain injur. Prog. 
Neurobiol. 83: 140-148. 
Wang, J. and Angulo, J.A. (2011) Synergism between methamphetamine and the neuroptide substance P on 
the production of nitric oxide in the striatum of mice. Brain Res, 1369: 131-139. 
Wilson, J.M., Kalasinsky, K.S., Levey, A.I., Bergeron, C., Reiber, G.,Anthony, R.M., Schmunk, G.A., Shannak, 
K., Haycock J.W., Kish , S.J. (1996) Striatal dopamine nerve terminal markers in human, chronic 
methamphetamine users. Nature Med 2:699–703 
Chapter 6 - References 
 
82 
Warren, M.W., Larner, S.F., Kobeis sy, F.H., Brezing, C.A., Jeung, J.A.,Hayes, R.L., Gold, M.S., Wang, K.K. 
(2007) Calpai n and caspaseproteolytic markers co-localize w ith rat cortical neuro ns afterexposure to 
methamp hetamine and MDMA. Acta Neuropathol 114:277-286. 
Wong, D., Prameya, R. and Dorovini-Zis, K. (1999) In vitro adhesion and migration of T lymphocytes across 
monolayers of human brain microvessel  endothelial  cells:  regulation by  ICAM-1,  VCAM-1,  E-selectin  and 
PECAM-1.  J Neuropathol  Exp Neurol, 58(2): 138-52. 
Wu, C. W., Ping, Y. H., Yen, J. C., Chang, C.Y., Wang,  S.F., Yeh,  C.L., Chi, C.W. and Lee,  H. C. (2007) 
Enhanced  oxidative  stress and  aberrant  mitochondrial  biogenesis  in human  neuroblastoma  SH-SY5Y  
cells  during methamphetamine  induced  apoptosis.  Toxicol Appl Pharmacol, 220: 243-251. 
Yamagata, K., Tagami, M., Takenaga, F., Yamori, Y. and Itoh, S. (2004) Hypoxia-induced changes in tight 
junction permeability of brain capillary endothelial cells are associated with IL-1beta and nitric oxide. 
Neurobiol Dis, 17:491-499. 
Yamamoto, B. K., Moszczynska, A. and Gudelsky, G. A. (2010) Amphetamine toxicities: classical and 
emerging mechanisms. Ann N Y Acad Sci, 1187: 101-121. Review. 
Yamamoto, B.K. and Raudensky, J.  (2008). The  role  of  oxidative  stress,  metabolic compromise,  and  
inflammation  in  neuronal injury  produced  by  amphetaminerelated  drugs of abuse. J Neuroimmune 
Pharmacol, 3: 203-217. Review.  
Zhu, P., Hata, R., Cao, F., Gu, F., Hanakawa, Y., Hashimoto, K. and Sakanaka, M.  (2008)Ramified microglial 
cells promote astrogliogenesis and maintenance of neural stem cells through activation of Stat3 function. 
FASEB J, 22(11):3866-77. 
 
